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Abstract

Biofilms are communities of microorganisms attached to surfaces through various selfsecreted matrix materials. Biofilms are dynamic communities with extensive interactions
between their residents. Microorganisms compete, cooperate, and communicate with each
other in biofilms. These ecological interactions determine the emergence or loss of
strains/species and are critical in the formation and proliferation of biofilms. Furthermore,
most natural biofilms are formed by multiple microbial species and strains and these
interactions within the biofilm dramatically influence community composition and
structure over time. Microbial interactions also influence clinically relevant outcomes such
as antibiotic resistance and host virulence. In this thesis we explore the potential
interactions of microbial populations with their environment, different strains and species
using a combination of molecular techniques, microfluidics, and confocal microscopy. In
the first study we explored surface competition and biofilm invasion strategies of two
strains of Pseudomonas aeruginosa. We found that different extracellular matrix
composition and biofilm production strategies effect their direct competition. One strain
was able to outcompete the later during early colonization and growth. In contrast the later
strain was able to better invade existing biofilms and more inclined to stay during starvation
conditions. This sheds light on the advantages of different colonization strategies and their
advantages in diverse environmental settings. In the second project, we explored the effect
of nutrition on Candida albicans biofilms by growing them in different media. We studied
C. albicans biofilm characteristics in three distinct nutritional niches and found that biofilm
architecture and properties were distinct in each nutritional niche. This study highlights the
importance of nutrient media, and the effects metabolism has on biofilm formation. Finally,
in the last project we studied the interaction of Pseudomonas aeruginosa and Candida
albicans in a Cystic Fibrosis (CF) lung environment. We found an increase in biovolume
for both species and this result was specific to the biofilm environment. Although we could
not identify the mechanism of action, we saw this robust result of increase of biovolume in
dual species biofilms across multiple mutants and CF isolates. These studies showcase the
importance of microbial ecology in understanding biofilm properties and characteristics.
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1.1 Abstract
Microorganisms commonly exist as communities and constantly interact with each other
and their environment. They can interact positively, negatively, or neutrally and these
interactions have a big impact on shaping the community as well as their environment.
Microorganisms can exist as spatially structured communities called biofilms, the spatial
structure enables swifter interactions because of spatial proximity to their neighboring
cells. Studying the spatial structure of microbial biofilms can enable us to understand their
underlying interactions, for example if species or strains are competing, they are likely to
spatially separate from each other. The sessile nature of biofilms allows us to track
microbial interactions changes temporally. The spatial structure and non-motile lifestyle
make microbial biofilms a good system to study microbial interactions.

1.2 Introduction
Microorganisms or microbes include bacteria, archaea, fungi, protists, and viruses and are
a highly diverse group of organisms. They are distributed globally ranging from the human
guts [1] to deep-sea hydrothermal vents [2] to aerosolized droplets [3]. Rather than existing
as single free-living or planktonic cells, microbes are known to form complex interactive
groups within their ecosystem. Microbes interact with other microbes of the same species,
of different species or with vastly different families and phyla[4], [5]. Microbial
interactions can span a multitude of mechanisms such as genetic or metabolic exchange,
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and chemical signaling. Microbe-microbe interactions are critical for the survival and
replication of microbial populations in various environments [6].

The basic unit of microbial interaction is gene expression in response to chemical or
physical stimuli. Differential expression of multiple genes leads production of chemical
molecules or microbial appendages that microbes use to interact with their environment
[7]. The nature and significance of these interactions depends on both abundance and type
of interacting organisms present as well as the physical environment and available
nutritional source. Microbes are not limited to a single kind of interaction, the transient
nature of their physical, chemical, and biological environment results in highly complex
and dynamic interactions[5], [8], [9].

FIG. 1: Classification of microbial interactions based on fitness cost to actor and recipient.
Cooperative and competition interactions cause a fitness decrease in the actors whereas there is no
fitness cost to the actor in neutral interaction.

Microbial interactions can be broadly classified based on fitness consequence for the
microbial actor and the microbial recipient (Figure 1). When there is an increase in fitness
for the recipient, the behavior is termed cooperative. These interactions can manifest as
3

mutualistic interactions, for example Vibrio cholerae produces chitinase, a secreted
enzyme to degrade its nutrient source, within the environment. When multiple V. cholerae
cells produce and secrete this enzyme into the environment, the increased concentration of
the enzyme can be beneficial for all producing members by increasing access to nutrients
[10]. Cooperative interactions can alternately be altruistic, where there is a fitness cost
incurred by the actor. For example, when Escherichia coli cells are faced with antibiotic
stress, a portion of cells produce a signaling molecule, at a cost to themselves, that helps
non-producing cells cope with the stress [11]. Interactions leading to fitness decrease for
the recipients is referred to as competitive interaction. Scarce nutrients and limited space
have led to several competitive behaviors in microbes using which they can outcompete
and displace their competitors. For example, Burkholderia thailandensis inhibits growth
of Bacillus subtilis by the production of antibiotics [12]. Finally, neutral interactions exist
when the actor does not incur an energy cost, but the recipient is positively or negatively
affected. For example, Bacillus cereus produces peptidoglycans as a product of its own
metabolism, and the presence of this peptidoglycan has shown to stimulate growth of
Rhizosphere bacteria [13].

Disentangling of microbial interactions and their underlying mechanisms can unravel
strategies that microbes use to establish and survive in different environments and
ecosystems. Understanding the effects of these interactions is essential to improving the
performance of many ecological systems that are important in diverse processes like
biological waste treatment, industrial fermentations, human or animal health, and disease
and in soil systems[6]–[8], [14], [15]. Microbial interactions research is still in its nascency.
Little is understood about the multidimensional nature of communication channels
microbe’s use. Exhaustive descriptions and detailed characterization of microbial
interactions will enable us to manipulate microbial communities and utilize them for
clinical, industrial, and biotechnological applications.

1.3 Microbial interactions: Cooperation and Competition
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(i)

Competition

Microbial populations need space and nutrients to grow and multiply. Most microbes live
in environments that have finite space and nutrients. The need to access these common
resources, gives rise to microbial competition [12]. Microbes usually overlap in resource
use and invest energy to cause a fitness decrease in their competitor. Antagonistic or
competitive behaviors can occur between unrelated species of different kingdoms or even
between the same strains of a species differing by a single mutation [16].

Microbes can compete two distinct ways (Figure 2) depending on whether they are actively
or passively engaging with their competitors.
1. Exploitative Competition
This kind of competition occurs passively through the consumption of a limiting
resource thereby denying access to the competitor. The indirect competition to
nutrients can occur through the increased uptake of nutrients and through release of
extracellular molecules that can harvest nutrients from their surroundings.
Additionally, competition can occur for space; microbes can rapidly colonize a
space and prevent the entry of others. Alternatively, microbes can push out or move
existing competitors as a consequence of faster growth or extracellular molecule
production to make space for themselves [17]. The fast growth or extracellular
molecule provides an advantage to the species producing it, however it is still
passive in the sense that it is also produced in the absence of the competitor.

2. Interference Competition
This in an active form of competition where the microbes directly interact and
physically impair their competitors. Secretion of toxic chemicals like antibiotics
can kill or damage competitors. Secretion of certain molecules can manipulate
competitor’s metabolism and prove advantageous to the secretor. Cells can also
starve their competitors and cut off access to nutrients through physical barriers.
Furthermore, direct competition can occur through physical contact, for example
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type VI secretion systems, where cells inject syringe-like protrusions containing
toxins and other molecules into neighboring cells [17].

FIG. 2: Diagrammatic representative of types of competitive behaviors. Exploitative competition
occurs passively through increase uptake of nutrients or rapid colonization / shoving behavior.
Interference competition on the other hand occurs through direct interaction.

A landmark study by Foster and Bell [18] compared pairwise interactions of 72 strains of
bacteria and found that the net benefits to the species involved remain relatively modest.
Based on these results they predicted that there are larger numbers of competitive
interactions between many species and fewer cooperative interactions. We know that
microbes have evolved a wide range of mechanisms to harm and kill their competitors that
include a multitude of chemical weapons and mechanical techniques. Microbial
competition is very diverse and complex shaped by many factors, including cell density,
nutrient abundance and spatial arranged of cells[12], [19]. The existence of all these
multiple competitive strategies reflects the principal role of microbial competition in
microbial ecology.

(ii)

Cooperation
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As referenced earlier, the key determinants of social behavior are fitness costs for the actor
and the recipient. An increase in fitness for the recipient, is termed cooperative.
Cooperative behavior could be mutually beneficial for the actor or altruistic (negative) for
the actor (Figure 3). In contrast, antagonistic behaviors result in a fitness decrease for the
recipients and could provide an advantage for the actor. This makes antagonistic and
mutually beneficial behaviors easier to explain in an ecological sense in relation to altruistic
behaviors.

FIG. 3: Diagrammatic representation of fitness cost to microbial actor on the left and recipient on
the right. Mutualistic interactions are positive to both actor and recipient. Altruistic interactions are
beneficial to the recipient and harmful to actor.
.

Cooperation presents two major theoretical challenges that must be understood in order to
determine how cooperation can arise:
1. The first challenge is to understand why an individual would carry out a costly
behavior for the benefit of other individuals.
Cooperative behaviors can be divided into two broad groups. The first is a direct
fitness advantage to the actor, the fitness advantage outweighs the cost of
performing the behavior. In this situation the cooperation is beneficial to both the
actor and receiver and there is usually a mechanism in place to enforce the
cooperating behavior and remove non-cooperators. A second kind of cooperative
behaviors decrease the direct fitness of the actor, however, there is an overall
increase in the fitness of that genotype. Altruistic behaviors are usually targeted
towards close relatives or clonemates and is termed as indirect fitness or inclusive
fitness.
7

To dive a little deeper, altruistic behavior can be explained by kin selection theory.
Helping a close relative to reproduce benefits the actor by passing on its own genes
to the next generation. This provides an indirect fitness advantage for the actor and
a direct fitness benefit for the receiver. The theory is encapsulated mathematically
in the form of Hamilton’s rule [20], which states that altruistic cooperation is
favored when rb-c > 0; r is genetic relatedness, b is the benefit to the recipient and
c is the cost of behavior to the actor. Altruistic cooperation can be expected when
relatedness or benefit are high, and cost of cooperation is low. For predominantly
asexual organisms like microorganisms, the concept of relatedness can be reduced
to genotypic view of the behavior. Genotypic identity could be a result of recent
clonal growth or horizontal gene transfer. If the genotypes that drive the interaction
are identical, altruistic cooperation is favored [16] .

2. In mutualistic cooperation, there is the problem of non-cooperative individuals or
cheaters, who could benefit by not cooperating and obtain a competitive advantage.
This concept can be illustrated by Hardin’s theory of the tragedy of the commons.
Consider a shared pastureland that many shepherds can use. Cooperation can exist
between the shepherds if they have fixed small number of sheep. This ensures the
pasture is not overgrazed, providing a net benefit for all the shepherds. But it is in
each individual shepherd’s benefit to add sheep to his flock, even though it may
cause exhaustion of the shared resource (grazing pasture) and reduce the benefit for
all shepherds. This leads to the collapse of cooperation.

Studies, however, have shown the existence of cooperative behaviors in
microorganisms. Take for example the production of public goods. Public goods
are products that are costly for an individual to produce but provide a benefit to the
population [21]. Iron scavenging molecules called siderophores are an example of
public goods produced by many bacteria in iron limiting conditions. Experiments
with P. aeruginosa [22] have demonstrated that wild type strains that produce the
siderophore and can grow faster in iron limiting conditions than do siderophore
non-producing mutant strains. However, in iron rich conditions, the siderophore
8

mutants grew faster demonstrating that there is cost to siderophore production.
However, it is possible in mixed populations the mutants can gain benefit of
siderophore production without paying the cost and able to out compete the wild
type of strain. In natural systems, this kind of invasion by non-cooperators or
cheaters can be minimized by a multiple stabilization mechanism like density
dependence, spatial structure, pleiotropy, metabolic prudence, and policing
behaviors [23]. These different techniques help keep cheaters out and ensure
cooperators are not outcompeted.

1.4 System to study microbial interactions: Biofilms
An ideal system to study microbial interactions given the size of the organisms, is one
which not only has a large enough population but also is non motile enabling tracking
changes spatially and temporally. Biofilms are such a system; we know that 40-80% of
microbial life exist as biofilms making them a very relevant system to study [24].
Biofilms are communities of microbes attached to surfaces through various self-secreted
matrix materials. The matrix, a canonical feature of biofilms, can be made of
polysaccharides, proteins, lipids, and extracellular DNA [25]. Biofilms are extremely
widespread in nature, they can colonize a variety of substrata like minerals, metals, plant
and animal cells and implanted medical devices like catheters and metal implants [8], [26]–
[29]. Fossil records have shown that biofilm formation is ancient process indicating that it
is a fundamental process in the microbial life cycle. A diverse spectrum of microorganisms,
including bacteria, fungi, and protists, have displayed biofilm formation likely indicating
that it is beneficial for survival.
Biofilms interact with their environment in ways that contrast with their planktonic counter
parts. For example, antimicrobial resistance of biofilm dwelling microbes is considerably
higher than their planktonic counter parts. Anti-microbial protection can be achieved by
reduction in metabolic and growth rates, protection by extracellular matrix and resistance
mechanisms conferred by the altered physiology of biofilm microbes [24]. Biofilm mode
of life confers other advantages to its members, such as adhesion/cohesion capabilities,
9

mechanical properties, nutritional sources, metabolite exchange platform, cellular
communication, protection from environmental stresses and host immune, and shear forces
[29].
Further, biofilms are a critical area of study because they are the most widely distributed
and successful modes of life on Earth. They drive biogeochemical cycling processes of
many elements in water, soil, sediment, and subsurface environments [30].
Biotechnological applications of biofilms include the filtration of drinking water, the
degradation of wastewater and solid waste, and biocatalysts in biotechnological processes,
such as the production of bulk and fine chemicals, as well as biofuels[31]. All higher
organisms, including humans, are colonized by microorganisms that form biofilms, which
can be associated with persistent infections in plants and animals, and with the
contamination of medical devices and implants[32], [33]. Biofilms also present technical
challenges and are responsible for biofouling and contamination of process water,
deterioration of the hygienic quality of drinking water and microbially influenced corrosion
[34], [35]. Understanding how biofilms form and function will allow use not only to
mitigate their negative effects but also maximize utilities they provide.

The exact molecular mechanisms of biofilm formation vary substantially among
microorganisms. However, the broad stages of biofilm development (Figure 4) are
conserved among them: (i) Initial attachment (ii) Microcolony formation (iii) Mature
biofilm (iv) Dispersal. It is important to note that different environmental stimuli can
trigger different biofilm developmental pathways, indicating that the process of biofilm
formation is very dynamic. Once attached, they start secreting a glue like material called
matrix and multiplying to give rise to small microcolony which eventually mature into
larger three-dimensional biofilms. Eventually the cells from the biofilm disperse into the
environment to find a new region to colonize [25], [29].
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FIG. 4: Representation of stages of biofilm formation for bacteria Pseudomonas aeruginosa.
Planktonic or free-floating cells attach to a surface after which they start to multiply and produce matrix.
The cells then expand vertically to form a three-dimensional amature biofilm. Finally, planktonic cells
are released from the biofilm back into the environment to find a new niche to colonize.

1.5 Effect of internal factors on spatial structure
(i)

Interactions

We know microbial biofilms can contain a diversity of strains (subtype of a species) and
species. As surface attached cells start to grow, they interact with other cells around them
and their environment causing the structure of their community to change. Because
biofilms are stationary, microbial social behaviors are limited to neighbors making spatial
structure crucial. Cells immigrating and emigrating from the biofilm, environmental stress,
predation, nutrient availability can all affect the structure and composition of biofilms [36].
Social interactions have been increasingly recognized as one of the major influencers that
contribute to microbial biofilms including their spatial structure [37]. To briefly consider
how interactions can shape biofilm dynamics and their spatial structure, consider an initial
population of three distinct cell lineages A, B and C (example from [37]). In the first
scenario, A is antagonistic and kills B and C, leading to a biofilm that contains only A.
Alternatively, in a scenario where B and C are mutualistic, they may tend to cluster towards
each other to maximize their shared benefit. In a third scenario, where B produces public
11

goods, B is likely to spatially localize with themselves away from A and C to prevent
cheating behavior. Therefore, studying the spatial structure of the biofilm could help us
understand underlying interaction and how these interactions in turn shape biofilm
characteristics and emergent properties.

FIG. 5: Representation of the effect of interactions on spatial structure of biofilms. If an initial
population starts with equal number of cells from three species (i) Species A is antagonistic and kills all
other cells, to a final population with only species A (ii) If species B and C are mutualistic, leads to a
final population where B and C might spatial collocate (iii) if species B produces public goods, it may
spatially isolate itself from other species to maximize its own benefits and prevent cheating behavior.

1.6 Effect of external factors on spatial structure
(i)

Fluid flow

Flow around a biofilm influences transport of solutes in and out of the biofilm and applies
forces to the biofilm that can affect its ability to attach and detach [38]. Flow primarily
exerts shear force onto the biofilm usually in the main direction of fluid flow, but complex
fluid mechanics like eddies and turbulent bursts can also result in additional force
components[39]. The movement of liquids and consequently the stress they introduce have
been shown to have physical effects on biofilms rolling, development of streamers,
oscillatory movement, and detachment [38]–[43]. Fluid flow around biofilms can also
affect mass transfer, they can act for example as an insulator for diffusive exchange. This
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in turn can exacerbate oxygen or nutrient limitation, affect quorum sensing, and contribute
to changes in spatial structure of the biofilm [44].
The flow regime can also affect the morphology and biofilm characteristic at their
microscale architectural space. For example, adaptation shear stress at cellular scale has
influenced the evolution of bacterial surface motility, surface colonization mechanisms,
extracellular matrix secretion, bacterial cell shape, planktonic aggregate formation, and
biofilm community assembly and function[39], [41], [42], [45]. However, flow mediated
changes in solute environment are another important fluid flow function that not explored
as well (Figure 6). Additionally, if and how shear stress initiates or represses the production
of certain secreted molecules used for microbial communication in unknown.

FIG. 6: Representation of potential effects of flow on secreted microbial products. The presence of
fluid flow may change concentration gradients and spatial location of microbially secreted products.
Flow may also induce production of novel products and inhibition of those produced under conditions
without flow.
.
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(ii)

Nutrient environment

Biofilm formation is a multistep process, involving multiple physiological changes that
takes place in response to environmental and biochemical factors. The amounts and types
of nutrients in the environment influence the development and composition of biofilms
[46]. In oligotrophic environments, for example, organisms respond to nutrient stress by
alterations in their cell morphology and cell surfaces, changing their adherence properties
[47].
Microbes can initiate, accelerate, facilitate, and block certain behaviours depending on the
amount and type of nutrients available. Although there have been studies of the effects of
nutrient concentrations on biofilm growth there have been fewer studies exploring the how
different kinds of nutrients effect biofilms [48], [49]. Biofilms are known to grow in a
multitude of habitats, these habitats are very nutritionally diverse and complex. In addition,
the metabolic flexibility of different microbes has been explored and documented.
However, the combination of these two areas is still under studied. An interesting area in
microbial biofilm research is to explore biofilm ecology in diverse nutritional environments
and to study the effect of nutrient type on biofilm form and function.

1.7 Microbial model system

(i)

Pseudomonas aeruginosa biofilms

P. aeruginosa is a gram-negative soil bacterium that is the focus of intense research
because of its role in disease because of long-term colonization and persistence. Metabolic
flexibility allows it to exploit several niches. Being an opportunistic pathogen, P.
aeruginosa is frequently isolates from human hosts with compromised immune systems.
Treatment of P. aeruginosa infections are hindered by its ability to form biofilms. Biofilms
not only protect the microbe from anti-microbial treatments but also provide protection
from environmental stress, and host defenses [50].
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Biofilm formation in P. aeruginosa starts with surface attachment (Figure 7). Planktonic
cells first contact a surface through reversible attachment [51]. Once this contact is made
the cells can move using twitching motility using type IV pilli or flagella and surfactants
to move across the surface[51]. Finally, cells can also commit to irreversible attachment
through the long axis of the cell. Following which surface proteins such as SadB or LapA
and secreted matrix components assist in adhesion between the cell and the surface [52],
[53]. c-di-GMP is a signaling molecule and secondary messenger molecule that regulates
transition from motile to sessile mode of growth. c-di-GMP is thought to act as a
checkpoint through the different stages of biofilm formation, increase in c-di-GMP can
modulate matrix production, stress responses, and inhibit motility [54]. cAMP is another
secondary molecule that has been shown to promote attachment and stimulate microcolony
formation [55]. Changes in cAMP concentrations by cells that have encountered a surface
have also been shown to be passed down temporally through clonemates. This temporal
passage of information can help in faster attachment to a surface [56].

FIG. 7: Surface attachment by P. aeruginosa. Once the cell contacts a surface it can leave, explore
the surface using type IV pilli or flagella and rhamnolipids. The cells can alternately, commit to
irreversible attachment by the production of adhesion proteins and secretion of matrix.
.

Following attachment, cells start to multiply and produce extracellular matrix. A canonical
feature of biofilms is their production of an extracellular matrix. The matrix provides a
protective environment and three-dimensional structure to the cells present in the biofilm
[57], [58]. Biofilm matrix composition varies depending on P. aeruginosa strain, although
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the different components of matrix are documented (Figure 8A), the trade-offs,
preferences, and advantages of different combinations of matrix composition are still under
investigation. The matrix of P. aeruginosa is largely made of exopolysaccharides – Psl and
Pel. Psl and Pel have been proposed to be involved in cell-cell and cell-surface adhesion.
They are also important in binding other matrix components like extracellular DNA and
host polymers like hyaluronan and mucin. Psl and Pel seem to be redundant in function,
some strains of P. aeruginosa only have Pel [57], [59], [60]. Another polysaccharide,
alginate was initially thought to be an important component of biofilm formation; however,
it is now accepted that alginate is not a significant component of the matrix. While P.
aeruginosa biofilms can be formed without alginate, alginate seems to be an important
component of defense mechanisms against host immune systems [61].

In addition to polysaccharides, the P. aeruginosa biofilm matrix also contains proteins and
extracellular DNA (eDNA). The protein CdrA has been shown to be important in biofilm
formation by anchoring Psl to the bacteria or by crosslinking of CdrA and Psl in addition
to retaining Psl in the biofilm matrix. CdrA-CdrA interactions have been shown to be
important in cell-cell packing in an aggregate that is resistant to physical shear [62]. LecA
and LecB are proteins also thought to be involved biofilm formation. LecA is believed to
be involved in cell-to-cell interactions within the biofilm thereby connecting the bacterial
cells together in biofilms [63]. LecB on the other hand is thought to be involved in cellmatrix EPS interactions [64]. eDNA in the P. aeruginosa matrix has been shown to provide
structural support. eDNA isolated from in vitro biofilms was identified to be derived from
P. aeruginosa genomic DNA in biofilms suggesting that eDNA was actively produced for
biofilm matrix [65], [66].
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FIG. 8: P. aeruginosa biofilm matrix composition and mechanism of dispersal. (A) Diagrammatic
representation of matrix components (B) representation of mechanisms involved in dispersal from a P.
aeruginosa biofilm.

Dispersal, a mode of biofilm detachment, indicates active mechanisms that cause
individual cells to separate from the biofilm and return to planktonic life. Since biofilm
cells are cemented and surrounded by EPSs, dispersal is not simple to do, and many
researchers are now paying more attention to this active detachment process. c-di-GMP as
mentioned earlier is an intracellular signal that regulates the transition from sessile to
planktonic growth in a variety of bacteria. Increased levels of c-di-GMP generally result in
an increase in exopolysaccharide and fimbriae production, and a decrease in motility,
whereas decreased levels of c-di-GMP exert the opposite effects and induce biofilm
dispersal [54]. P. aeruginosa dispersal from biofilms can occur through one or combination
of mechanisms. Cells can detach from the biofilm through the degradation of biofilm
matrix using an endonuclease EndA, they can also return to motile lifestyle by investing in
flagella [67], [68]. Alternately, they have been also shown to produce surfactants called
rhamnolipids which have shown to be important in motility [69]. P. aeruginosa can also
differentiate spatially ahead of dispersal to form hollows inside biofilms form which
planktonic cells reenter the environment [70] (Figure 8B).
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(ii)

Candida albicans biofilms

C. albicans is a prevalent polymorphic fungal commensal and colonizes many areas of the
body in healthy individuals. However, any alterations in host immunity can lead to C.
albicans infection. They are known to notoriously colonize implanted medical devices like
catheters, pacemakers, dentures and prosthetic joints. C. albicans, like P. aeruginosa,
depends on its ability to thrive as a biofilm [71].
C. albicans biofilm formation is represented in Figure 9 and begins with yeast cells
contacting a surface, these early interactions are thought to comprise non-specific factors
like attractive forces and electrostatic interactions facilitate initial surface contact[72].
Following surface contact, cell-wall associated molecules are expressed to attach.
Agglutinin-like sequence (Als) family of proteins have been shown to facilitate yeast cellcell and cell-substrate adhesion [73]. Once the yeast cell is attached to a surface, it starts to
germinate to form hyphae and psuedohyphae [71]. In addition to Als family of adhesion
proteins hyphal wall proteins and Iff/Hyr family of adhesion proteins have been shown to
be important in cell-cell and cell-surface adhesion maintenance [74].
Adhesion is followed by biofilm development, which includes changes in morphology,
increase in biomass and secretion of extracellular matrix. Filamentous morphology
provides support and structural integrity to the biofilm in addition to providing a scaffold
for yeast cell attachment [75]. Mutants defective in hyphae production for example were
shown to be defective in biofilm formation [76]. The extracellular matrix is essential for
biofilm development and maturation. C. albicans matrix contains 55% exopolysaccharides,
most common of which are β-1,6 glucan and α-mannan, which interact to form a mannose
glucose complex. A total of 565 different proteins have been identified in the C. albicans
matrix that constitute 25% of the biofilm matrix. This suggests a non-canonical secretion
pathway or the accumulation of proteins after cell death. C. albicans biofilms also contain
eDNA (5%) in their matrix, it was demonstrated that C. albicans eDNA is largely
composed of random non-coding sequences. Finally, the matrix has about 15% lipids that
are yet to be characterised and studied [77], [78].
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FIG. 9: Diagrammatic representation of biofilm formation by C. albicans. Yeast cells attach to a
surface through adhesion proteins followed by filamentation. This is followed by matrix production and
cell multiplication. Final step in biofilm formation is dispersal, yeast cells are released from the top
layers of the biofilm.

The final piece of biofilm lifestyle is dispersal, where cells are released from mature
biofilms into the environment to find a new niche to colonize. The majority of dispersal in
C. albicans biofilms occurs from the top layers of the biofilm and associated with yeast
cells [79]. Additionally, studies of in vitro biofilm development indicate that cells are
probably dispersed continuously throughout biofilm formation [80]. Although these
dispersed cells morphologically resemble the round yeast cells seen in the planktonic mode
of growth, they have distinct characteristics. For example, the dispersed cells have
increased adherence properties, and have a higher capacity to form biofilms, relative to
planktonic cells. Although these dispersed cells morphologically resemble the round yeast
cells seen in the planktonic mode of growth, they have distinct characteristics. For example,
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the dispersed cells have increased adherence properties, and have a higher capacity to form
biofilms, relative to planktonic cells [81].

Transcriptional regulators are DNA binding proteins that regulate transcription; they play
pivotal roles in co-regulating target genes that function together to achieve a specific
function. A primary study of transcriptional regulators by Nobile et al led to the
identification of six master regulators responsible for biofilm formation. The regulators
form an elaborate interconnected network, each regulator controlling the other and each
target controlled by more than one regulator. The authors present the explanation for the
complexity of the circuit as a response to a wide range of environmental cues. Consistent
with this idea they provide the example of the regulator Bcr1 that plays an important role
in biofilm formation in the catheter model but has less pronounced role in the denture
model [82]. Currently it is approximated that there are about 58 transcriptional factors
collectively influencing close to 1000 genes involved in different stages of biofilm
formation that include filamentation, adhesion, metabolism, and production of matrix [83].

(iii)

Pseudomonas aeruginosa – Candida albicans interactions and dual species
biofilms

In the context of disease microbes usually grow as biofilm communities, these communities
are often polymicrobial in nature. Although most natural biofilms are polymicrobial, most
of our current knowledge about biofilms comes from study of single species [14], [84].
Interactions between members of different species can alter host responses, virulence and
pathogenesis and usually increase the severity of the infection [14]. Examples of human
polymicrobial infections include cystic fibrosis lung infections, biomaterials and implants
related infections, urinary tract infections and diabetic ulcers. P. aeruginosa and C.
albicans are two opportunistic pathogens often co-isolated from a variety of these human
polymicrobial infections[8], [83]–[88].
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FIG. 10: Diagrammatic representation of microbial interactions between P. aeruginosa and C.
albicans. These interactions include both contact dependent and independent mechanisms.

P. aeruginosa and C. albicans have been known to form recalcitrant polymicrobial
biofilms that place considerable burden in infections they are involved in, explaining the
bulk of research on their interactions (Figure 10). The primary findings reported P.
aeruginosa killing the C. albicans hyphal cells however this did not extend to yeast cells
[89]. This effect was further confirmed to be morphology specific, with the bacteria
showing extensive attachment to the fungal hyphae. This colocalization and killing has
been implicated in nutrient competition, with P. aeruginosa using type IV pilli and lectin
binding carbohydrates to make the physical association [90]. P. aeruginosa has known to
secrete acyl-homoserine lactone (AHL) molecule called 3-oxo-C12-HSL a quorum sensing
molecule controlled by the Pseudomonas quinolone signal (PQS) sensing circuit which can
inhibit yeast to hyphal switch [91]. This inhibition compromises C. albicans ability to form
biofilms. The bacterium also produces a suit of toxins called phenazines, one of which is
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pyocyanin. Pyocyanin has been shown to reduce cAM required of biofilm formation and
generates ROS both negatively affect the biofilm formation of the fungus [88]. On the
contrary, P. aeruginosa proteolytic enzymes have been shown to increase C. albicans
virulence and in vivo experiments using a zebrafish model have indicated mutually
enhanced virulence of the two species, suggesting that environmental shifts may have
strong impacts on the properties of cocultures of these microbes [92].

C. albicans also secretes several factors that have been shown to effect P. aeruginosa
metabolism and biofilm formation. One such secreted molecule is Farnesol, it can inhibit
pyocyanin production and rhamnolipid mediated swarming motility. Farnesol has
traditionally been associated with hyphal to yeast transition [93]. Another secreted
molecule called Tyrosol which is involved in yeast to hyphal switch has been shown to
decrease P. aeruginosa virulence [94]. Ethanol is a common fermentation product
produced by many bacteria and fungi; it has been shown to influence P. aeruginosa in
diverse polymicrobial settings. In polymicrobial infections where P. aeruginosa coexists
with C. albicans, exogenous fungal-produced ethanol has been shown to inhibit phenazine
production and promote biofilm formation. In addition, ethanol enhances bacterial Pel
matrix production and represses surface motility. This is believed to be a feedback loop
whereby C. albicans produces ethanol, which increases biofilm formation, inhibits
swarming motility, and enhances the production of antifungal phenazines on the part of P.
aeruginosa [95], [96]. Competition for iron is also one of the main antagonistic interactions
occurring in P. aeruginosa-C. albicans infections. Enhanced secretion of P. aeruginosa
siderophore pyoverdine in mixed species biofilms leads to a decrease in iron availability
on C. albicans and inhibits yeast growth [97].

1.8 Conclusions and Outlook
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Biofilms are surfaced attached groups of microbial cells; they are believed to be the
dominant mode of growth for microbial cells. Biofilms have distinct properties in relation
to their planktonic counter parts, spatial location of cells especially plays an important role
[24]. The spatial proximity of cells in biofilms not only creates a conducive environment
for contact dependent interactions but also for contact independent interactions. Most
secreted molecules move as a consequence of diffusion and bulk transport, the spatial
structure of the population will determine the extent to which these molecules will be
consumed by or effect neighbouring cells [43]. Microbial cells are also influenced by the
availability of nutrients and environmental factors like shear stress from flow. These factors
funnel into changes in metabolism which in turn effect microbial interactions and secreted
molecules which ultimately influence biofilm characteristics [38], [39].

In recent years, the number of studies examining microbial interactions in biofilms has
increased however, we have only begun to scratch the surface of a very important topic in
microbiology. These studies are relevant to multiple microbial environments that include
medicine, industry, and biogeocycling, highlighting importance of microbial interactions
and their influence on biofilm form and function. One of the challenges of establishing
model systems for studying microbial biofilms under controlled, laboratory conditions is
to preserve or recreate the relevant microenvironment. Microbial interactions are important
at the microscale in biofilms, however most studies on biofilms often lack the microhabitat
and spatial information.

Advances in new technologies like microfluidics coupled with microscopy have improved
our ability to study a variety of microbial habitats along with providing spatial information
at single cell resolution. Nonetheless, there is much to understand about the details of
microbial interactions in ecologically relevant niches. Several important questions are yet
to be explored. How do microbial interactions shaped by spatial structure, nutrient
availability, and other environmental factors and in turn effect their environment? How do
specific environments shape microbial spatial structure? What effect does microbial
metabolism have on spatial structure? What typical effects do spatial structure have on
biofilm function? Using established biofilm models like those of P. aeruginosa and C.
23

albicans we can start to answer these questions that will ultimately help us understand the
ecological dynamics that occur within biofilms that relate to the compositional changes in
community structure and biofilm function.
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2.1 Abstract

Pseudomonas aeruginosa strains PA14 and PAO1 are among the two best-characterized
model organisms used to study the mechanisms of biofilm formation while also
representing two distinct lineages of P. aeruginosa. Previous work has shown that PA14
and PAO1 use different strategies for surface colonization; they also have different
extracellular matrix composition and different propensities to disperse from biofilms back
into the planktonic phase surrounding them. We expand on this work here by exploring the
consequences of these different biofilm production strategies during direct competition.
Using differentially labeled strains and microfluidic culture methods, we show that PAO1
can outcompete PA14 in direct competition during early colonization and subsequent
biofilm growth, that they can do so in constant and perturbed environments, and that this
advantage is specific to biofilm growth and requires production of the Psl polysaccharide.
In contrast, P. aeruginosa PA14 is better able to invade preformed biofilms and is more
inclined to remain surface-associated under starvation conditions. These data together
suggest that while P. aeruginosa PAO1 and PA14 are both able to effectively colonize
surfaces, they do so in different ways that are advantageous under different environmental
settings.
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2.2 Introduction

Biofilms are surface-attached microbial communities that mediate long-term growth and
persistence on substrates as varied as vegetable produce and indwelling medical devices
(1, 2). Biofilms are typically polymicrobial in nature and exhibit an increased tolerance to
antimicrobial agents, predation, and reactive oxygen species (3–7). The transition from
planktonic to biofilm modes of growth is complex and uses signaling systems initiated by
surface engagement that have downstream consequences for biofilm formation (8–10). To
form a biofilm, motile bacteria such as Pseudomonas aeruginosa use appendages including
flagella and pili to mediate early surface engagement (11, 12). Surface colonization and
growth during biofilm formation are also linked to extracellular polysaccharide (EPS)
production, which provides cell-to-surface and cell-cell adhesion (13). For some species,
EPS matrix is crucial for early surface attachment (13); matrix material also strongly
influences biofilm architecture and structural integrity (14, 15), collective biophysical
properties (16–18), and the population dynamics of different strains and species competing
for space and resources (19).

Our understanding of biofilm formation comes in part from the study of the PA14 and
PAO1 strains of P. aeruginosa, a Gram-negative bacterium that forms prolific biofilms in
aquatic environments, soils, and clinical settings (20–23). This species uses two distinct
signaling systems to initiate biofilm formation (24, 25): the second messenger c-di-GMP,
which is regulated through the Wsp system (26–28), and the second messenger cyclic AMP
(cAMP), which is regulated through the Pil-Chp/Vfr system (29, 30). Prior work
documenting variation in propensity of PAO1 and PA14 to commit to surface attachment
have intimated those different strains of P. aeruginosa more heavily rely on different
components of the signaling pathways controlling biofilm initiation. PAO1, for example,
commits to surface attachment and extracellular matrix secretion relatively quickly via the
Wsp system-mediated increases in c-di-GMP production (28, 31, 32). PA14 surface
commitment control may instead be dominated by signaling via the Pil-Chp system
initiated through type IV pili (TFP) engaging a surface, which in turn transmits this surface
signal to the adenylate cyclase, CyaB. The activation of CyaB increases concentrations of
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cAMP, resulting in production and secretion of cell surface localized PilY1. The PilY1
protein participates in the activation of diguanylate cyclase SadC by an unknown
mechanism to enhance c-di-GMP production (30, 33–36).

P. aeruginosa PAO1 and PA14, both isolated from infected wounds (37, 38), represent two
distinct lineages based on whole-genome phylogenetic analysis (39). As noted above, they
differ in their pattern for committing to surface attachment; their matrix compositions differ
as well: both produce Pel, but PAO1 produces a major matrix polysaccharide, Psl, that
PA14 lacks (40–42). The overall result is that these two strains exhibit distinct surface
association strategies: PAO1 commits relatively quickly to attachment and matrix
production after surface contact, while PA14 shows a nonprocessive mode of surface
commitment in which cells frequently disengage from surfaces after initial contact while
their progeny are primed for subsequent reattachment through a cAMP-dependent
signaling pathway (25, 30, 43, 44).

Although PAO1 and PA14 are both heavily studied as models for biofilm formation, there
is relatively little work exploring the adaptive rationale for their distinct surface association
and biofilm commitment strategies. Biofilm production is very expensive both in terms of
metabolic cost and opportunity cost if poorly timed relative to environmental suitability,
and the differences in biofilm production strategy between strains and species may often
reflect adaptations to different ecological circumstances (45–47). These niche-specific
conditions may include, for example, variation in the typical lifetime of a given location
patch for growth, the longevity of important nutrient supplies, and whether encountered
surfaces are usually bare or already occupied by other bacteria. On the basis of the
mechanistic differences in how PAO1 and PA14 control surface attachment and
commitment to matrix production, we explore how these two strains compete against each
other in model biofilms, studying in particular their population dynamics and spatial
structure with respect to each other in coculture versus monoculture. We find that their
distinct biofilm production strategies do indeed have significant consequences for the
outcome of competition and that PAO1 and PA14 are best suited for surface occupation
under different environmental circumstances.
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2.3 Results

PAO1 outcompetes PA14 in dual-strain biofilms.

To test if the colonization strategies used by P. aeruginosa PA14 or PAO1 impart an
advantage during the initial colonization of a clean surface, we used microfluidic devices
in which bacteria can be monitored as they attach and grow on glass substrata. To allow
for visualization of each strain by fluorescence microscopy, constitutive fluorescent protein
expression constructs were introduced, with GFP and mKO-κ inserted at the att site of
PAO1 and PA14, respectively (48).

To assess competition during early biofilm formation, PAO1 and PA14 were inoculated
into microfluidic chambers in a 1:1 ratio and imaged over 7 h of flow in a buffered minimal
medium containing 1.0 mM K2HPO4, 0.6 mM MgSO4, and 0.4% arginine. We measured
the fold change in fluorescence for each strain over time normalized to 0 h; PAO1 showed
a significant advantage in biomass accumulation over PA14 as early as 4 h after surface
inoculation. After 7 h of incubation, the number of PAO1 cells was ∼2-fold greater than
that of PA14 (Fig. 1A to C).
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FIG. 1 PA14-PAO1 dual strain biofilm population dynamics. (A, B, and D) Representative widefield
fluorescence (A and B) and confocal (D) images of PA14-PAO1 coculture biofilms at the time points
indicated under each image. Biofilms were inoculated with a 1:1 mixture of each strain at 0 h. The same
color scheme for PAO1 (green) and PA14 (magenta) is used in all panels here and in all figures. (C)
Quantification of early surface coverage by each strain (0 to 7 h). n = 3, P < 0.05 after 5.5 h by 2-way
ANOVA with Sidak posttest. (E) 3D rendering of a PA14-PAO1 dual-strain biofilm at 24 h. (F) Cutaway
3D rendering of the same biofilm in panel E, showing its internal structure. (G) Change in frequency of strain
WT PAO1 as a function of its initial frequency in dual-strain biofilms with WT PA14. n = 9 nonoverlapping
image stacks from 4 separate microfluidic devices. Error bars denote the standard deviations

41

If the observed advantage of PAO1 during biofilm competition was due to enhanced
growth rate or antagonistic interactions with PA14 via diffusible secreted factors, one
would expect a similar competitive outcome in mixed liquid culture conditions. We tested
this possibility by growing planktonic PAO1 and PA14 in glass tubes containing sterile
biofilm medium either in monoculture or 1:1 coculture. PAO1 and PA14 grew equally well
when cultured separately (see Fig. S1A in the supplemental material), and neither strain
outgrew the other in mixed planktonic cultures (Fig. S1B). Notably, the CFU counts of the
strains in a coculture were lower by similar measures than their respective CFU counts
when grown alone; this indicates neutral competition in which the two strains compete for
limited resources in mixed liquid coculture, but neither has an advantage over the other.
These results suggest that the advantage in biofilm competition for PAO1 is not due to
higher basal growth capacity but rather to other root causes.

Biofilms often exhibit complex architectures that can vary significantly in mixed-strain or
mixed-species contexts (49–53); in light of these observations, we next assessed the
population dynamics and spatial structure of PAO1 and PA14 allowed to grow for longer
periods in biofilm coculture. The two strains were grown together in microfluidic chambers
for 24 h and then imaged by confocal microscopy. Consistent with the pattern observed in
early-stage biofilms inoculated with a 1:1 ratio of PAO1 and PA14 (Fig. 1A to C), after
24 h PAO1 appeared to overgrow PA14 (Fig. 1D). Z-projections of confocal image stacks
revealed that PAO1 grows across the top of the PA14 cell clusters (Fig. 1D to F), consistent
with a previous study competing different strains of PAO1 that vary in their matrix
production (54).

he above-described data provide evidence that when grown in the biofilm context, PAO1
has an advantage against PA14 during early colonization and 24 h of biofilm growth. Thus
far, a 1:1 inoculation ratio of PAO1 to PA14 was used to assess dual-strain population
dynamics. This condition does not account for the possibility of frequency-dependent
selection, in which the outcome of competition may depend on the initial ratio of the two
strains. To test if the competitive advantage of PAO1 was frequency dependent, we varied
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the starting PAO1 relative abundance and measured the change in frequency of PAO1
versus PA14 after 24 h. Regardless of the starting conditions, PAO1 consistently increased
in frequency over PA14 (Fig. 1G), and PA14 biovolume accumulation was suppressed in
coculture with PAO1 relative to when PA14 was cultivated on its own (Fig. S2A and B).
The pattern shown in Fig. 1G is characteristic of uniform positive selection that would
ultimately lead to complete displacement of PA14 by PAO1 during successive rounds of
biofilm competition. We also tested whether changes in initial surface colonization density
might affect these population dynamics and found that they did not (Fig. S2C). We
conclude from these experiments that under the flow conditions used here, PAO1
outcompetes PA14 in a frequency- and density-independent fashion.

Psl is required for PAO1 to outcompete PA14 in biofilm competition.

We have provided evidence that PAO1 robustly outcompetes PA14 when both are grown
together in biofilms under flow. To clarify the mechanism of these dynamics, we attempted
to alter the competition outcome by manipulating the biofilm formation capacity of PAO1
or PA14. P. aeruginosa produces three extracellular polysaccharides (EPS) known to
facilitate biofilm formation: Pel, Psl, and alginate (55). Alginate is broadly conserved in
pseudomonads but only conditionally expressed in PAO1 and PA14 during periods of
stress (41, 56, 57) and was shown previously to not contribute to in vitro biofilm formation
by these strains (41). PAO1 and PA14 both produce Pel, while Psl is unique to PAO1 (58,
59). Previous work has also shown that Psl is a cooperative resource among secreting cells
but that cells that do not produce it are excluded and outcompeted in a PAO1 background
(54). We hypothesized that Psl provides an advantage for PAO1 not afforded to PA14 and
tested a PAOl mutant with a clean deletion of the psl promoter (referred to as the PAO1
Δpsl mutant here) against PA14 during biofilm growth. Loss of Psl production eliminated
the competitive advantage of PAO1 in biofilm coculture with PA14, and indeed the PAO1
Δpsl mutant decreased in relative abundance by over 40% in chambers inoculated with a
1:1 mixed culture (Fig. 2; see Fig. S3A for absolute initial and final frequency data). This
result was entirely explained by the dynamics of competition during biofilm growth
between PAO1 and the PAO1 Δpsl mutant rather than differences in colonization of the
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glass at the start of the experiment (Fig. S3A). As a baseline control, we also competed
WT PAO1 against the PAO1 Δpsl strain, which recapitulated earlier work showing that
WT PAO1 overgrows and outcompetes its isogenic Δpsl deletion mutant (Fig. S3B and C)
(54).

FIG. 2 Competitive dynamics of PAO1 and PA14 with altered piliation or matrix production
capacity. This figure reports the change in frequency of WT PAO1 and the PAO1 Δpsl mutant in
coculture biofilms with WT PA14 as well as the change in frequency of WT PAO1 in a dual-strain
biofilms with PA14ΔpilU, PA14 ΔbifA, and Pel-overproducing strains (Pel O/E) supplemented with
arabinose. Biofilms were inoculated with a 1:1 mixture of each strain pair (n = 9 to 18 nonoverlapping
image stacks from 4 to 6 separate microfluidic chambers). Error bars denote the standard deviations;
Wilcoxon signed-rank tests with Bonferroni correction were used for pairwise comparisons; *, P < 0.05;
all other comparisons were not significant.
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We next explored whether the inverse manipulation of increasing PA14 biofilm production
capacity could allow it to better compete against WT PAO1. First, we took advantage of
the observation that type 4 pili (T4P) have been shown to mediate initial attachment by P.
aeruginosa (12), and recent work showed that manipulation of T4P functions may enhance
surface commitment by PA14 (44). Specifically, we tested if the PA14 ΔpilU mutant,
which is hyper-piliated, shows high constitutive cAMP signaling, and rapidly colonizes
surfaces, would gain a competitive advantage when grown in a biofilm with PAO1. This
was not the case; the PA14 ΔpilU mutant was outcompeted by PAO1 by a margin
comparable to that of wild-type (WT) PA14 (Fig. 2). Taking note of the absolute initial and
final frequency data (Fig. S3A), whereas all other strain pairs initially colonized the
chamber glass surfaces at ∼1:1, reflecting the 1:1 mixed liquid cultures introduced to the
microfluidic chambers to initiate these experiments, the ΔpilU PA14 strain was
outcompeted by PAO1 even at this initial colonization stage. Against the ΔpilU PA14
mutant, PAO1 was overrepresented on the surface after the inoculation period from a 1:1
mixed liquid culture and subsequently increased in relative abundance even further
(compare red and blue data points in Fig. S3A).

Next, having shown that Psl plays an important role in the PAO1 strain’s ability to compete
against PA14, we reasoned that PA14 might gain an advantage, or at least mitigate its
disadvantage, through hyperinduction of its primary matrix polysaccharide, Pel. To test
this hypothesis, we first used a ΔbifA mutant, which we showed previously displays
increased c-di-GMP signaling and enhanced Pel polysaccharide production (60), but the
PA14 ΔbifA mutant was not any more successful against PAO1 than WT PA14. As an
alternative approach, we next used a strain that expresses the pel operon under the control
of an arabinose-inducible promoter (designated Pel O/E). Interestingly, while induction of
pel expression with 0.2% arabinose increased biofilm accumulation of this strain in
monoculture (Fig. S3D), its competitive ability under either arabinose condition was not
enhanced relative to that of WT PA14 when grown with PAO1 (Fig. 2). Finally, we used
a variant of the Pel O/E strain that also overproduced c-di-GMP due to a mutation in the
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wspF gene (designated Pel O/E ΔwspF); again, this strain, when induced with 0.2%
arabinose, did not show enhanced fitness against PAO1 compared to the PA14 parent strain
(Fig. 2) despite enhanced biomass in monoculture (Fig. S3D). Taken together, these data
show that Psl production is a key factor allowing PAO1 to outcompete PA14 and that
enhancing PA14 biofilm production via several different strategies does not mitigate
PA14’s disadvantage against Psl-producing PAO1 during biofilm formation.

PAO1 outcompetes PA14 during dispersal from one patch to another.

Competition for access to space and nutrients in one location is important for evolutionary
fitness, as is the ability, when required, to disperse to new locations for future growth (61).
Bacteria that commit strongly to biofilm production in a given location may experience a
trade-off in their ability to disperse to new locations (45, 62), so we explored whether
introduction of a simulated dispersal regime influences the outcome of competition
between PA14 and PAO1. We grew a 1:1 mixture of PA14 and PAO1 in microfluidic
chambers under flow for 20 h, after which we introduced a dispersal stage. For each such
event, the outflow tube from the first microfluidic chamber was attached to a second, clean
chamber, and the biofilm effluent was used to seed the downstream chamber for 2 h. The
goal was to imitate the natural transition of P. aeruginosa from an existing biofilm to a
new environment with an intervening planktonic phase (Fig. 3A, top).
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FIG. 3 PAO1 outcompetes PA14 in a dispersal regime. (A) Graphical summary of dispersal
experiment regime (top) and representative images of biofilms in serially inoculated chambers (bottom).
(B) The frequency of PAO1 in dispersal experiments through serially inoculated chambers with
intervening 20-h incubations. All error bars denote standard deviations (n = 9 nonoverlapping image
stacks from 4 separate microfluidic chambers).

In biofilms coinoculated 1:1 with PAO1 and PA14, PAO1 accounted for ∼70% of the
population at the end of the 20-h incubation (Fig. 3A and B), consistent with experiments
in the sections described above. Following the first transfer to a new chamber and 20 h of
incubation, PAO1 rose in relative abundance to an average of 97% of the total population.
After the second transfer and 20 h of incubation, PAO1 had reached fixation; that is, it
comprised 100% of the population in all sample image stacks (Fig. 3A and B). These data
indicate that PAO1 suffers no disadvantage during dispersal steps and, as predicted by the
population dynamics data in Fig. 1H, drives the PA14 strain entirely out of coinoculated
biofilms after successive rounds of biofilm competition punctuated by dispersal events.
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The results reflect the net outcome of competition during surface colonization, subsequent
biofilm growth, dispersal into the effluent liquid phase, recolonization of downstream sites,
and new rounds of biofilm growth.

It is possible that in the experiments described above, PA14 dispersal out of biofilms
incubated for 20 h was blocked due to PAO1 overgrowing and locking PA14 into place in
the lower layers of the cocultured biofilms. We assessed this possibility by repeating the
serial chamber inoculation experiment described above, but we allowed for only 3 h of
incubation before each dispersal event. We chose 3-h incubations because PAO1 could not
overgrow PA14 in this short of an interval. As there were relatively few cells departing the
chambers after 3 h of coculture incubation, too few cells were found on the surface of
downstream chambers to reliably quantify, so we instead calculated the strain frequencies
observed in chambers after 3 h of incubation and then inoculated new chambers with the
same strain frequencies but at ∼500-fold higher density. With this experimental regimen,
PAO1 was again found to increase in frequency from one chamber to the next but had not
yet reached 100% of the population by the end of the experiment (Fig. S4). Therefore,
shortening the biofilm incubation periods between chamber transfers did not alter the
qualitative result that PAO1 consistently displaces PA14, but it did slow the speed at which
PAO1 does so.

Differential response of PAO1 and PA14 in biofilms subject to starvation.

The experiments described in the previous section suggest that PAO1 exceeds PA14 in its
dispersal during simulated disturbance events in which the cells leaving an existing biofilm
under normal flow conditions must colonize a new location. Disturbance events can be
more concrete, for example, when nutrient supplies are suddenly cut off at a given location
due to depletion or change in flow conditions. Indeed, nutrient supply in many natural
environments may more often occur in transient bursts rather than continuously.
Considering these factors, we explored how PAO1 and PA14 in coculture biofilms would
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react to carbon starvation. We grew dual-strain biofilms for 12 h and then changed the
influent flow to a carbon-free (but otherwise equivalent) biofilm medium for 4 h. Following
the switch to nutrient-depleted medium flow, PA14’s surface coverage reduced by 5%,
while that of PAO1 decreased by 40% (Fig. 4A, B, and E). To see if this result would hold
for larger biofilms incubated for longer periods prior to starvation, we repeated this
experiment after allowing the coinoculated biofilms to grow for 24 h. Once again, the total
amount of PA14 remained nearly unchanged following starvation, while that of PAO1
decreased in this case by nearly 60% (Fig. 4C, D, and F).
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FIG. 4 Responses of biofilm-dwelling PAO1 and PA14 to nutrient depletion. Coculture biofilms of
PAO1 and PA14 were grown for 12 h or 24 h and deprived of their carbon source (arginine) for 4 h. The
surface area occupied by PAO1 and PA14 in 12-h-old biofilms (coinoculated at 1:1) was measured
before (A) and after (B) carbon deprivation. (E) Fold changes in surface area occupied by each strain
are shown. The total biovolumes of PAO1 and PA14 in 24-h-old biofilms (coinoculated at 1:1) were
assessed before (C) and after (D) carbon deprivation. (F) Fold changes in the biovolume of each strain
are shown. Error bars denote standard deviations (n = 3 for panel E; n = 8 nonoverlapping image stacks
from 4 separate microfluidic chambers for panel F). Error bars denote the standard deviations. Wilcoxon
signed-rank tests with Bonferroni correction were used for pairwise comparisons; *, P < 0.05.

To clarify whether cell death was occurring in biofilms following carbon depletion, we
repeated these experiments once again, growing 1:1 coculture biofilms of PA14 and PAO1
for 24 h prior to starvation; in this case, the starvation media lacking carbon also contained
propidium iodide (PI), whose diffusion into cells is an indicator of compromised membrane
integrity and cell death. We found no PI staining until 3 h after the switch to carbon-free
media, with somewhat more cell death in PA14 than PAO1 (Fig. S5A). A similar result
was reflected in the cells collected from the liquid effluent of the chambers for the full
duration of the starvation treatment (Fig. S5B).

These data and those of the previous section suggest that PAO1 is more inclined to disperse
from existing cell monolayers and from biofilms several cell layers in depth, during both
continual influx of carbon-replete media and following a sudden loss of a carbon source.
PA14 is slower to commit to biofilm production but also more inclined to stay in place if
nutrient supplies are cut off for short periods.

PA14 is more proficient than PAO1 at invading resident biofilms.
The data described above suggest that PAO1 is proficient at outcompeting PA14 during
early surface colonization and subsequent biofilm growth as well as during successive
rounds of serially connected new locations to inhabit. Following nutrient deprivation,
PA14 mostly retains its occupied surface, while PAO1 is more inclined to disperse. So far,
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all experimental regimes in the preceding sections have challenged the two strains to
colonize and compete in previously unoccupied locations, but in more natural contexts one
might imagine that colonizing bacteria instead encounter surfaces that are already occupied
by other strains and species. Our next experiments were designed to assess the relative
abilities of PA14 and PAO1 to invade preexisting biofilms of the other strain.
Here, we grew a biofilm of one of the strains in monoculture, which we refer to as the
resident strain. After 12 h of growth of the resident strain, we introduced the second strain
(the invader) for 4 h to assess its ability to colonize and integrate into the resident biofilm.
By visual inspection alone it was evident that PAO1 showed minimal invasion into resident
PA14 biofilms (Fig. 5A and B), while PA14 was considerably better able to invade
preformed biofilms of PAO1 (Fig. 5C and D). To quantify invasion efficiency by PAO1
and PA14, we measured the fold change in total fluorescence of the invading strain over
the 4-h invasion assay. PA14 invades resident PAO1 biofilms rapidly, whereas PAO1
hardly invades resident PA14 biofilms at all (Fig. 5E). In separate experiments that
repeated this invasion protocol using resident biofilms that had been incubated for 24 h, we
also measured the total biovolume of the invading strain after 4 h. By the end of the assay,
PA14 invading biovolume was ∼100-fold higher than that of PAO1 invading a resident
PA14 biofilm, as measured by confocal microscopy (Fig. 5F).
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FIG. 5 Reciprocal invasion dynamics of resident biofilms. Resident biofilms of PA14 were grown
for 12 h and invaded by PAO1 for 4 h (A, widefield fluorescence image; B, confocal optical section and
z-projection). Resident biofilms of PAO1 were grown for 12 h (A, C, and E) or 24 h (B, D, and F) and
invaded by PA14 for 4 h (C, widefield fluorescence image; D, confocal optical section and z-projection).
(E) The invasion efficiency of PA14 (purple) and PAO1 (green) was measured over time by normalizing
the change in fluorescence intensity from the start of the assay through 4 h of invasion. n = 3, P < 0.05
after 3 h by 2-way ANOVA with Sidak posttest. (F) The total invading strain biovolume of PAO1 and
PA14 at the end of the invasion assay (n = 6 nonoverlapping image stacks from 4 separate microfluidic
chambers). Error bars denote the standard deviations. P < 0.05 by Wilcoxon signed-rank test
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2.4 Discussion
Biofilms are spatially and physiologically heterogenous environments in which bacteria
both cooperate and compete intensely with each other for access to space and resources.
Biofilm formation itself is increasingly conceptualized as a core response to ecological
competition (19, 63, 64), and here we investigated reference strains P. aeruginosa PAO1
and PA14 for their ability to compete with each other in the context of biofilm growth.
Long studied as models of biofilm formation, these two strains of P. aeruginosa vary
substantially in their regulatory mechanisms of surface attachment and compositions of
secreted extracellular matrix (16, 25, 42, 44, 65). We show that under microfluidic biofilm
culture conditions, PAO1 quickly outcompetes and overgrows PA14 in a density- and
frequency-independent manner. PAO1 and PA14 were also found to spatially segregate
over 24 h, with PA14 mostly limited to the substratum and PAO1 overgrowing PA14.

That PAO1 begins to outnumber PA14 in the early (2 to 7 h) stages of surface occupation
is most likely attributable to the difference in their patterns of surface attachment. Prior
work has intimated that PAO1 commits quickly to surface adhesion and extracellular
matrix secretion relative to PA14 (25, 44). Following surface colonization, subsequent
differences between PAO1 and PA14 in their extracellular matrix begin to contribute to
their population dynamics. This interpretation is reinforced by the fact that the competitive
advantage of PAO1 is specific to the biofilm mode of growth, during which PAO1
produces matrix containing Pel and Psl, while PA14 only produces Pel. Psl production by
PAO1 was essential for its advantage against PA14 under flow and was the dominant
controlling factor (of those we examined here) for the outcome of competition; no other
physiological manipulation that we tested could alter the outcome of competition between
the two.

Others have highlighted Psl production as fundamental to competition in biofilm
environments for P. aeruginosa, including when isogenic strains are competed against each
other (54) and when PAO1 cohabits biofilms with other species, such as P. protegens and
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Klebsiella pneumoniae (65). Extensive work has explored the relative roles of the Pel and
Psl polysaccharides of the P. aeruginosa extracellular matrix (42, 66), indicating that they
offer some structural redundancy to one another in strains that can produce both, such as
PAO1. There is also evidence that Pel and Psl make different contributions to the
viscoelastic properties and spatial structure of Pseudomonas biofilms. Of particular note,
Chew et al. (16) found that Psl is important for extracellular matrix cross-linking and
overall matrix elasticity, strengthening biofilms and promoting microcolony formation
extending from basal substrata. Pel, on the other hand, tends to increase biofilm viscosity,
encourage streamer formation (67, 68), and facilitate lateral spreading (16). Paralleling the
observations we made here, Chew et al. also found that Psl-producing PAO1 formed
mixed-species biofilms in which it grew over the top of Staphylococcus aureus, while Psldeficient PAO1 was less able to overgrow S. aureus in coculture (16).

An additional important element of fitness for any biofilm-producing microbe is balancing
investment into local competition versus dispersal (69). Previous work has linked relative
investment in matrix production to trade-offs in this balance (62). Here, we explored how
PAO1 and PA14 disperse in two different ways, measuring the propensity of each to leave
biofilms passively during normal flow of nutrient-replete medium and the propensity of
each strain to disperse during a starvation event. We found that PAO1 was more prone to
dispersal under both conditions. In serially colonized chambers during flow of nutrientreplete medium, PAO1 ultimately displaced the PA14 strain. Under starvation conditions
in which we only studied single chambers subjected to nutrient deprivation, we saw that
PA14 was far more strongly inclined to stay in place. Thus, PA14 may be more suited to
retaining a grip on space it has occupied when nutrients run low, even as some of its
population dies under starvation, while PAO1 is more inclined overall to disperse. The
relative advantage of staying in place under starvation conditions depends on the prevailing
environmental conditions: if local nutrient supply fluctuates, then remaining in place may
be the better strategy, but if nutrient supply does not return once depleted, then dispersal
will be optimal.
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Our final series of experiments showed that PA14 is markedly better able to colonize a
previously established biofilm of PAO1 than vice versa, by 2 orders of magnitude, over a
relatively short colonization and growth time scale of 4 h. This suggests that PA14 is better
suited to exploiting previously colonized environments, while PAO1 is superior in
dispersing to and then competing for space and resources on unoccupied surfaces. Recent
genomic analysis has found that strains similar to PA14 predominate among CF-derived
isolates, while the PAO1-like strains are more likely to be encountered among
environmental isolates (70) (noting, though, that the original PA14 and PAO1 isolates both
came from wounds). We speculate on the basis of our results that PA14 has evolved a
surface occupation strategy best suited to taking advantage of previously colonized
surfaces and commitment to staying in place under fluctuating nutrient conditions, while
PAO1 is better suited to rapid exploitation of unoccupied surfaces followed by rapid
dispersal under nutrient limitation to find new locations for future growth. Due to the
enormous diversity of environments in which bacterial biofilms grow, we imagine these
are just two among many possible strategies that evolved to optimize surface occupation
among Pseudomonas and other bacterial species.

2.5 Material and Methods
Strains and media.
Strains of P. aeruginosa are all derivatives of PAO1 or PA14 and were constructed by
standard allelic exchange. The biofilm growth substrate was buffered minimal medium
containing 1.0 mM K2HPO4, 0.6 mM MgSO4, and 0.4% arginine. Starvation medium
omitted arginine and, for the cell death assays, contained propidium iodide at 2 μg/ml.
Microfluidic device assembly.
The microfluidic devices were made by bonding polydimethylsiloxane (PDMS) chamber
molds to size number 1.5 cover glass slips (60 mm by 36 mm [length by width]; ThermoFisher, Waltham, MA) using standard soft lithography techniques (71). Each PDMS mold
contained 4 chambers, each of which measured 3,000 μm by 500 μm by 75 μm (length by
width by depth). To establish flow in these chambers, medium was loaded into 1-ml BD
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plastic syringes with 25-gauge needles. These syringes were joined to number 30 ColeParmer PTFE tubing (inner diameter, 0.3 mm), which was connected to prebored holes in
the microfluidic device. Tubing was also placed on the opposite end of the chamber to
direct the effluent to a waste container. Syringes were mounted to syringe pumps (Pico
plus elite; Harvard Apparatus), and flow was maintained at 0.5 μl/min for all experiments.
Note that while this flow rate is 100-fold lower than that used for some other biofilm growth
protocols with P. aeruginosa (25), it results in similar average flow velocities through our
PDMS microfluidic chambers, which are likewise ∼100-fold smaller in cross-sectional
area than commercial flow devices like those used in Lee et al. (44).
Biofilm growth.
Overnight cultures of P. aeruginosa PAO1 and PA14 were grown at 37°C with shaking in
lysogeny broth (LB) prior to the start of biofilm experiments. Cultures were normalized to
an optical density at 600 nm (OD600) of 1.0 in KA biofilm medium containing 50 mM
Tris-HCl (pH 7.4), 0.6 mM MgSO4, 1.0 K2HPO4, and 0.4% arginine (72). If coculture
biofilms were being grown, equal volumes of cultures adjusted to an OD600 of 1.0 were
mixed and used as the inoculum for the microfluidic chamber (completely filling its inner
volume), and then the bacteria were allowed to rest for 1 h at room temperature to permit
cells to attach to the glass surface. For the experiments with varied initial frequencies, after
cultures of each strain were adjusted to an OD600 of 1.0, different ratios of the two cultures
were added to obtain the desired frequency prior to inoculation. After resting for 1 h to
allow surface attachment, the devices were run at 0.5 μl/min at 37°C and imaged by
widefield or confocal microscopy (see below) at time intervals that varied per experiment,
as noted in Results. At every sampling time point, images were acquired from 3 or more
nonoverlapping locations within each biofilm chamber. All experiments were repeated
with at least 3 biological replicates with 3 or more technical replicates on different days.
Total replicates for each experiment are noted in the figure legends for each data set in the
text and supplemental material.
For the serial chamber inoculation experiments, dual-strain biofilms (1:1 initial frequency
of PA14 to PAO1) were incubated for 24 h or 3 h (Fig. 3; see also Fig. S4 in the
supplemental material), and a 0.5-cm length of tubing was connected to the outlet channel.
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At every sampling time point, images were acquired from nonoverlapping locations within
each biofilm chamber. The outlet chamber was then allowed to seed a new chamber for
2 h, initiating chamber 2. Chamber 2 was then incubated for 20 h, imaged, and used to seed
chamber 3 in a similar manner. The same procedure was performed for the version of this
experiment in which biofilms grew for only 3 h prior to being used to seed the next
downstream chamber, with one exception. Because very few cells exited chambers
incubated for only 3 h, there were too few of them found in the connected downstream
chambers to quantify. To compensate for this issue, we quantified the relative abundance
of PAO1 and PA14 at the end of chamber 1 after 3 h of incubation and then inoculated a
new chamber with the same strain relative abundances, except with about a 500-fold
increased density, to allow sufficient biomass to accumulate to determine the relative
frequency of each strain at the beginning of biofilm growth in the downstream chamber.
For invasion experiments, we grew the resident biofilm for 12 h at a medium flow rate of
0.5 μl per/min at 37°C, after which we introduced the invading strain (adjusted to an
OD600 of 1.0) at the same flow rate for 4 h by switching the chamber inlets to new tubing
connected to new syringes containing the invading strain. At every sampling time point, at
least 3 images were acquired from nonoverlapping locations within each biofilm chamber.
For the version of this experiment for which we used confocal microscopy, we grew
resident biofilms for 24 h prior to invasion to ensure that the resident biofilms completely
covered the glass substratum before the invading strain was introduced to the chambers.
Microscopy and image analysis.
Biofilms in the microfluidic chambers were imaged using a Zeiss LSM 880 microscope
with a 40×/1.2-numeric-aperture (NA) or 10×/0.4 NA water objective (confocal imaging)
or a Nikon Eclipse Ti inverted microscope with a Plan Apochromat 100× DM oil objective
(widefield imaging). For confocal imaging, a 543-nm laser line was used to excite mKOκ, and a 488-nm laser line was used to excite GFP; for widefield imaging, mKO-κ and GFP
were imaged using standard mCherry and fluorescein isothiocyanate filter sets. All
quantitative analysis of confocal microscopy data was performed using BiofilmQ (73).
Confocal two-dimensional (2D) sections and Z-projections were generated using Zeiss Zen
software, and 3D renderings of biofilms in Fig. 1 were generated using Paraview.
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Widefield images were generated using the native Nikon Elements software and analyzed
using ImageJ.
Starvation assay.
For the biofilm starvation studies, dual-strain biofilms (1:1 initial frequency of PA14 to
PAO1) were incubated for 12 h or 24 h, after which inflow ports were reconnected to new
tubing connected to new syringes containing medium identical to the original incubation
medium but without the carbon source (arginine). For the version of this experiment with
12-h biofilms, images were taken by widefield microscopy every 10 min for 4 h. For the
version of this experiment with 24-h biofilms, images were taken immediately after the
start of starvation (0 h) and then once more at the end of the starvation period (4 h). In
another version of this experiment for Fig. S5 with 24-h biofilms inoculated with 1:1
PAO1-PA14, propidium iodide was added to the starvation medium (2 μg/ml) that lacked
arginine, and images were taken every 1 h for 4 h to monitor propidium iodide uptake by
PAO1 and PA14 as a proxy for cell death. Effluent during the course of the 4-h starvation
was collected into a 1.5-ml Eppendorf tube on ice (to stop any further cell division). Cells
in the effluent were then collected and placed under agar pads for imaging to determine the
fraction of dead cells that had dispersed from the biofilm during the starvation treatment.
Statistics.
All statistical analyses were performed in GraphPad Prism. Pairwise comparisons were
performed using Wilcoxon signed-rank tests with Bonferroni correction. The comparisons
in Fig. 1C and 5E were performed by 2-way analysis of variance (ANOVA) with a Sidak
posttest. All error bars indicate standard deviations unless otherwise noted.
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2.6 Supplemental figures

FIG. S1. Well-mixed liquid culture growth comparison of PA14 and PAO1 in monoculture and
co-culture. PA14 and PAO1 were back-diluted 1:10 from overnight cultures and allowed to6 regrow
into exponential phase for 3 hr prior to being back-diluted once again to OD 600 = 0.057 either on their
own (A) or together at a 1:1 starting ratio (B). Population size in stationary phase8 was measured by
colony forming unit (CFU) count. n = 3; error bars denote the standard deviation. PAO1 and PA14 were
not significantly different from each other in mono-culture or co-culture by10 2-way ANOVA with a
Sidak post-test.
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FIG. S2. Absolute growth rate dynamics in biofilm co-cultures of PA14 and PAO1, and
tests for density-dependence of the PAO1 biofilm competitive advantage. (A) The biovolume
accumulation of PA14 and PAO1 in co-culture from a full spectrum of initial frequencies of the
two strains. (B) The total biovolume of both strains from each initial condition in (A). Data from
(A) and (B) are the same as those from Figure 1G of the main text, visualized in a different way
n = 9 non-overlapping image stacks from 4 separate microfluidic chambers. Error bars denote the
standard deviation. (C) Competition between PA14 and PAO1 from approximately 1:1 initial
inoculation at three different initial culture densities used for inoculation. For each inoculation
density, n = 9 non-overlapping image stacks from 4 separate microfluidic chambers; error bars
denote the standard deviation.
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FIG. S3. Control biofilm competition experiments with strain PAO1 and Pel over
expression strains of PA14. (A) Absolute initial and final frequencies of PAO1 (and in once case
PAO1 Dpsl) against PA14 and isogenic strains with altered piliation or matrix production. The
change-in-frequency data in Figure 2 are derived from the final and initial frequencies displayed
in this panel. n = 9-18 non-overlapping image stacks from 4-6 separate microfluidic chambers;
error bars denote the standard deviation. (B,C) Biofilm competition of PAO1 against itself and
against a PAO1 mutant with reduced Psl production. n = 4-9 non-overlapping image stacks from
2-4 separate microfluidic chambers; error bars denote the standard deviation. (D) Biofilm
production of PA14 WT in mono-culture and in three strain backgrounds with augmented Pel
production by overexpression in trans for Pel, or with the wspR deletion. n = 4-9 non-overlapping
image stacks from 2-4 separate microfluidic chambers; error bars denote the standard deviation.
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FIG. S4. PAO1 outcompetes PA14 in a high-frequency dispersal regime. (A) Graphical
summary of dispersal experiment regime (top) and representative images of biofilms in serially
inoculated chambers (bottom). (B) The frequency of PAO1 in dispersal experiments through
serially inoculated chambers with intervening 3 hr incubations. All error bars denote standard
deviation (n = 9 non-overlapping image stacks from 4 separate microfluidic chambers).
Population densities exiting the 3 hr-incubated biofilm chambers were too low to consistently
colonize subsequent chambers with sufficient surface coverage. To adjust for this effect, the final
frequencies of each strain in chambers following their 3 hr incubation were used to seed
downstream chambers, but at higher cell density to obtain sufficient surface coverage for seeding
the next chamber’s biofilm growth
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FIG. S5. Tracking cell death following carbon starvation in growing biofilms and dispersed
cells in the effluent liquid phase. Biofilms inoculated with a 1:1 mixture of P. aeruginosa PAO1
and PA14 were incubated for 24 h under constant flow, after which the inflow tubing was switched
to a new syringe containing carbon-free medium and propidium iodide (2μg/mL) at room
temperature. The biofilms were imaged 1/hr for 4 hr, and effluent from these chambers was
collected continuously into chilled storage tubes, from which samples were taken for imaging at
the end of the experiment. (A) The frequency of living PA14 and PAO1 cells (cell with zero
propidium iodide staining) within biofilms undergoing carbon starvation for 4 hr. n = 6 nonoverlapping image stacks from 3 separate microfluidic chambers. Error bars denote the standard
deviation. (B) The fraction of living PA14 and PAO1 cells in the effluent collected over 4 hr of
carbon starvation. Effluent was collected separately for n = 6 independent microfluidic chambers;
error bars denote the standard deviation
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3.1 Abstract
C. albicans is an opportunistic pathogen found in diverse human niches, including human
gut, skin, and medical devices, and can form robust biofilms in all these chemically variable
clinical sites. We studied C. albicans biofilm characteristics in three distinct nutritional
niches – one synthetic and two host niche mimic media. We found that biofilm architecture
and properties like morphology, biovolume accumulation, strength of attachment and local
biovolume packing were distinct in each nutritional niche. Finally, in experimental
methods novel to fungal biofilms, we explored the ability of C. albicans cell’s ability to
integrate into existing biofilms and found that it was dependent of a combination of local
biovolume packing and total biovolume.

3.2 Introduction
Candida albicans is a fungal commensal and a common member of the healthy human
microbiome [1]. In individuals with a healthy immune system, C. albicans can be found in
gastrointestinal tract, reproductive tract, oral cavity, and skin, often kept in balance with
the surrounding microbial communities. However, changes in the microbiota, host immune
system or local environment can enable pathogenic switch in C. albicans causing it to
overgrow and cause infection [2]. Reversible morphological plasticity between yeast,
pseudo hyphal and true hyphal forms is an important virulence factor that facilitates disease
establishment and proliferation [3]. In fact, non-filamentous C. albicans has been shown
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to be avirulent [4]. C. albicans can grow as biofilms which are highly structured groups
composed of these multiple cell types encased in a self-secreted matrix. These C. albicans
biofilms are intrinsically resistant to conventional antifungal therapies, host immune
defenses, and environmental perturbations, making them a significant clinical challenge
[5].

The majority of C. albicans infections are associated with its ability to form biofilms.
Studies have shown biofilm development to occur in a series of sequential steps. The initial
step consists of the attachment of unicellular yeast cells onto a surface forming a foundation
of a basal yeast. This is followed by cell proliferation across the surface and filamentation.
Filamentation is accompanied by the accumulation of an extracellular polysaccharide
matrix [5]. Finally, yeast cells bud off the tips of hyphal cells and are released from the
biofilm into the surroundings where they can colonize other surfaces [6]. Dispersion of
biofilm-associated cells carries great clinical significance as released cells can initiate
formation of new and more virulent biofilms [7].

C. albicans can form robust biofilms in several host nutritional niches during its pathogenic
lifestyle. It is most often identified in nosocomial infections capable of invading several
host sites from deep tissues and organs to superficial sites [8]. More significantly, C.
albicans is adept at adhering to catheters and various indwelling medical implants and is
also a commonly isolated bloodstream pathogen in hospitalized patients [9]–[11]. The
fungus has vast nutritional flexibility allowing it to adapt readily to the nutritional milieu
that it encounters. It has an uncommon capability to simultaneously use different carbon
sources. This nutritional flexibility is essential for colonization of diverse and complex host
niches [12].

C. albicans metabolism in response to nutrient availability has been shown to impact its
pathogenic behavior. Metabolic adaptation can impact changes in nutrient assimilation, cell
wall remodeling, expression of virulence factors and immune surveillance [13]. There has
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been growing evidence of differing degrees of stress resistance and virulence with differing
nutrient availability at the molecular scale [14]. However, if and how biofilm architecture
and characteristics – an important virulence mechanism in C. albicans – vary with respect
to available nutrients is not well understood. Further, how external factors like flow and
sheer stress effect biofilms in variable nutrient niches affect C. albicans biofilms have not
been explored.

Using fluorescently labelled C. albicans and microfluidic techniques we explore C.
albicans biofilm formation and architecture in synthetic and biologically relevant mimic
media. We show that C. albicans biofilm characteristics like morphology, biovolume and
strength of attachment are dependent on nutritional environment. We show that the ability
of planktonic cells to integrate into existing biofilms was dependent on local biovolume
packing and total biovolume. There was greater degree of integration of new strain into
existing biofilm in natural human host niches, a potential novel recorded behavior of C.
albicans virulence that could be the cause of clinically challenging C. albicans infection
outcomes.

3.3 Results

Biofilm description in synthetic media and host niche mimic media

We aimed to characterize the architecture and properties of C. albicans biofilms in the
presence of different nutrient profiles. We used RPMI, a synthetic nutrient rich media used
for growing and studying C. albicans across labs. We compared this with a cystic fibrosis
lung environment mimic media – artificial sputum media for confocal imaging (ASMi)
[15] – a modified version of the artificial sputum media developed by the Whiteley group
[16]- and artificial urine media – two nutritional mimic media of natural host sites where
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C. albicans biofilms have been shown to be present and prevalent[17-18]. C. albicans was
modified by allelic exchange to contain a chromosomal construct for constitutive
expression of GFP or mKate2 under the control of pACT promoter[15], [19]. GFP and
mKate2 were selected for these studies for their brightness and because they could be easily
distinguished by fluorescence microscopy.

To investigate C. albicans biofilm growth under flow of RPMI, ASMi and urine media, we
inoculated derivatives of strain CAI4 in microfluidic devices (see Materials and Methods).
First, the extent of attachment in each media was documented. For this C. albicans was
grown at 30oC overnight to ensure yeast cell morphology [20], after which OD normalized
cells were suspended in the respective media and inoculated into microfluidic chambers.
The cells were allowed to attach to the glass cover slip for an hour at 37oC. Confocal images
after 1h incubation showed that the amount of biovolume on glass were comparable across
the three media (Fig. 1A). Following this flow of media was initiated in the chambers and
biofilms were allowed to grow for 24h. Confocal imaging and biovolume quantification
showed that there was most biovolume accumulation in RPMI followed by ASMi and the
least in urine (Fig. 1B). Interestingly we saw variability in biovolume accumulation and
biofilm architecture especially in natural host niche mimic media (Fig. 1B Sup. 1). We
hypothesize this type of heterogeneity in total biovolume accumulation and architecture
could be characteristic of naturally found C. albicans biofilms because of the variability of
nutrient profiles in host niches.

Confocal images showed that the RPMI chambers contained highly filamentous and dense
biofilms, C. albicans looked to contain true hyphae with extensive knitting (Fig. 1Di).
ASMi chambers in contract contained majority pseudo hyphae as its filamentous
morphology and relatively reduced amount of biovolume (Fig. 1Dii). The biofilms grown
in artificial urine had the least amount of biovolume and were also in majority in their true
hyphal form, however, the hyphae looked shorter in comparison to those that grew in RPMI
(Fig. 1Diii).

77

FIG. 1: C. albicans biofilms in different nutrient environments. (A) Biovolume per unit area of
glass cover slip of attached C. albicans cells after 1h incubation at 37oC in three different media
(n=4) (B) Biovolume of C. albicans biofilms grown under flow at 37oC for 24h per unit area of
glass in three different media (n=9) (C) Biovolume per unit of C. albicans biofilms before and after
flow rate was increased to 5000 times the original for 3mins – mechanical stress (n=4-5)
(D)Representative 3D confocal renderings of C. albicans biofilms grown in (i) RPMI media (ii)
ASMi media (iii) Urine media.

C. albicans biofilms have not only been shown to be resistant to treatment by antifungal
but are also resistant to mechanical forces [12], [21-23]. Biofilms formed especially on
catheters are very hard to remove and usually results in replacement of the entire medical
device [21]. We were curious to see if and to what extent nutrient media played a role in
strength of attachment and resistance to mechanical stress. We grew C. albicans biofilms
in the three media underflow for 24h and then increased the flow rate to 5000 times the
original for 3mins to stimulate exposure to high mechanical stress. We show that strength
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of attachment is growth media dependent, the biofilms grown in RPMI showed no change
in biovolume after application of mechanical stress, whereas the biofilms in ASMi and
urine showed 60-80% reduction in total biovolume (Fig. 1C). Though there is reduction in
biovolume in ASMi and urine, impressively there is still biovolume left at the end of the
mechanical stress treatment (Fig. 1C Sup. 2) that could potentially lead to recolonization
of that space pointing to the ability of C. albicans biofilms to overcome mechanical
clearance in host niches.

Frequency distribution of local biovolume packing in C. albicans biofilms

The microscale architecture of a biofilm is the result of a combination of external factors
like shear stress and nutrient availability and internal factors like matrix composition and
microbial interactions. Cellular scale architecture in turn can affect the biofilm
characteristics like strength of attachment to a surface or resistance to mechanical forces.
Cellular ordering and structural adaptations can additionally inform us about the potential
expression of genes across the biofilm.
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FIG. 2: C. albicans biofilms local biovolume packing. (A) The frequency distribution of local
biovolume packing at 15 µm radius of 24h old C. albicans biofilms grown at 37OC under flow in (n =9)
(i) RPMI (ii) ASMi (iii) urine. The lines represent the median (B) Representative 3D confocal images
showing local packing in biofilms grown in (i) RPMI (ii) ASMi (iii) Urine. (C) Heat map of local
biovolume packing for representative images of biofilms grown in (i) RPMI (ii) ASMi (iii) urine.

Given the heterogeneity of biofilms formed in the three different media across the entire
microfluidic chamber (Sup. 1) we looked at biofilm at a smaller scale. BiofilmQ segments
the confocal image into cubes of a given length to acquire spatial data. For each segmented
C. albicans biovolume, we looked at the biovolume packing in a 15µm radius which
quantifies the biovolume of C. albicans that occupies space around each segmented C.
albicans in a radius of 15µm. The frequency distribution of local biovolume packing was
plotted across samples (Fig. 2A). The frequency distribution of biovolume packing was
similar between RPMI and ASMi relative to that of C. albicans biofilm grown in urine
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media. In C. albicans biofilms grown in RPMI, we see more normal distribution of
frequency distribution of biovolume packing with a peak at about 0.19 (Fig. 2Ai). This
suggests an even density packing across the biofilm, this can be visualized in both the
representative image and heat map of biovolume packing (Fig 2. Bi and Ci). For biofilms
grown in ASMi, the peak of the distribution is one sided (Fig. 2Aii) suggesting denser areas
in some parts of the biofilm. This is illustrated in the representative confocal image and
heat map of biovolume packing (Fig 2. Bi and Ci). Finally, in the biofilms in urine media
we see a large fraction of samples closer to zero biovolume packing (Fig. 2Aii) suggesting
a very sparsely populated biofilm. This is evident in representative confocal image and heat
map (Fig. 2 Biii and Ciii).

We observed that biofilms grown in RPMI, and urine were both filamentous, however their
frequency distribution of local biovolume packing were very different. Differences in
metabolism could be resulting in changes in matrix composition and quantity of
components produced. Interestingly, we see similar areas of local density packing in
biofilms grown in RPMI and ASMi even though the first is in hyphal morphology and the
later in pseudo hyphal morphology. From the previous section we also saw that the strength
of attachment is not dependent on local biovolume packing suggesting to us again the
matrix composition could potentially be altered between biofilms grown in these two
media. An interesting area for future work is to explore adhesion proteins and matrix of C.
albicans grown in these different media under flow.

Combination of frequency distribution of local biovolume packing and resident
biovolume in C. albicans biofilm determines invisibility

So far, in the preceding sections we have explored C. albicans ability to colonize and grow
in previously unoccupied locations. Another natural context one might imagine is that the
colonizing microbe could instead encounter surfaces that are already occupied by other
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strains and species. Our next experiments were designed to assess the relative abilities of
C. albicans to invade preexisting biofilms grown in different nutritional media.

Here, we first grew biofilms of C. albicans in the three media, which we refer to as the
resident strain. After 24h of growth of the resident strain, we introduced the second strain
(the invader) for 2h to assess its ability to colonize and integrate into the resident biofilm.
By visual inspection alone it was evident there was minimal invasion into resident biofilms
grown in RPMI (Fig. 3A Sup. 4A), while there was considerably higher invasion into
biofilms grown in ASMi and urine (Fig 3A Sup. 3B 3C). To quantify invasion efficiency,
we first quantified the frequency of invading strain 2h post invasion (Fig. 3A). Next, we
plotted biovolume of the invading strain 2h post invasion as a function of resident biofilm
packing density (Fig 3B). We found in the case of biofilms grown in RPMI with more even
distribution of local biovolume packing shown in the previous section, the invading cells
were not able to establish themselves in the resident biofilm. In the case of ASMi biofilms,
the invading cells were able to establish themselves in a local biovolume packing
dependent manner with high invader biovolume in low density packing (Fig. 3B). The
differences in combination of local biovolume packing and total biovolume results in
changes in invisibility of C. albicans biofilms grown in RPMI versus ASMi. Finally, in the
urine media resident biofilms were so sparely packed that the invader was able to establish
themselves at relatively high biovolume throughout the entire resident biofilm as is evident
in high frequency of invading strain (Fig. 3A and 3B)
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FIG. 3: C. albicans biofilms invasion dynamics. (A) The frequency or the relative fraction of invader in
a biofilm with both invader and resident strains are plotted as a function of the C. albicans resident strain
biovolume per unit area of glass (n=9) (B) Biovolume of invader strain in a total area imaging of
250000µm3 was plotted as a function of the local biovolume packing of the resident C. albicans strain
(n=9).

Invading C. albicans can displace resident C. albicans and integrate into resident
biofilms grown in artificial urine media
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FIG. 4: Biofilm invasion dynamics in urine media. (A) Biovolume of isogenic strains at 26h and 72h
in together and invasion experiments (n=3) (B) Biovolume of invading and resident C. albicans strains
during the course of invasion experiments (n=6) (C) The total biovolume in invasion and no invasion
experiments normalized to initial biovolume at 24h biofilm growth (n=3-6) (D) Representative 3D
confocal images through the course of an invasion experiment)

We conducted two sets of experiments. The first in which two isogenic strains of C.
albicans were introduced into the chamber at the same time and allowed to grow; this set
of experiments will be referred to as together. Next, we grew one isogenic strain which we
refer to as resident strain for 24h under flow and then introduce the second strain called
invader strain for two hours; these experiments will be referred to as invasion. We noticed
that in urine media the biovolume of two isogenic strains of C. albicans grown together
and in invasion experiments had comparable biovolumes at 26 and 72 hours after the start
of the experiments (Fig. 4A). This observation was very interesting and suggested that the
final composition of a dual strain C. albicans biofilm was not dependent on its initial
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inoculation conditions, irrespective of when in the lifecycle of the biofilm two C. albicans
come in contact, it seemed to lead to a well-mixed biofilm.

We found that the introduction of the invader strain caused a decrease in resident strain
followed by an increase in invader strain (Fig. 4B 4D). The decrease in invader biovolume
was from the tubing change performed to introduce the invading strain, in the control the
resident strain was able to regrow to its original biovolume at 24h before the tubing change
(Sup. 4). However, in the case of the invasion experiment, the invader replaced the resident
and integrate into the resident biofilm and increase in total biovolume (Fig 4B). It is
possible this kind of behavior is common in natural niches associated with urine and C.
albicans infections. Cells dispersing from the top of a urinary catheter could interact with
a downstream biofilm in this manner. Alternately disseminating cells from the blood could
encounter existing biofilms in the urinary tract. The integration of a more virulent strain
into an existing resident biofilm could lead to worse disease outcomes. This brings to light
yet another feature of robustness of a C. albicans biofilm characteristic and consequently
another challenge we face for its removal.

Lastly, when the biovolume is normalized to resident strain biovolume at 24h just before
the start of the invasion experiment, the total biovolume (invader + resident) in the
chambers through the experiment seemed to be regulated and hovered around the original
biovolume at 24h (Fig 4C). This regulation of biovolume was also seen in single strain
biofilm growth over time. This kind of regulation of biovolume or stable biovolume despite
accesses to nutrition and space has been implicated in commensal to pathogenic switch in
C. albicans [22]. Interestingly that study showed that C. albicans was present primarily in
its yeast morphology during this regulation. In contrast we see that C. albicans in
filamenting and in a biofilm. This novel behavior of biovolume regulation could have
important ecological functions. For example, it could be a potential mechanism to evade
immune system detection. Further work is necessary to understand the functions of such
behavior.
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3.4 Materials and Methods

Strains and media
C. albicans strains are derivatives of strain CAI4. All strains were grown on YPD (10 g
yeast extract, 20 g peptone, and 20 g dextrose [all amounts per liter]), RPMI 1640 (Sigma
– Aldrich), ASMi [15] and artificial Urine (Pickering Laboratories - 1700-0018). RPMi
and RPMI was bought from the commercial sources as mentioned.

The fluorescently labelled strains of C. albicans GPF and mKate2 were obtained from
Barelle et al., 2004 [19] and Kasetty et al., 2021 [15] respectively.

Microfluidic device assembly
The microfluidic devices were made by bonding polydimethylsiloxane (PDMS) chamber
molds to size #1.5 cover glass slips (60 mm 36 mm) [length L width W], Thermo-Fisher,
Waltham, MA) using standard soft lithography techniques (96). Each PDMS mold
contained four chambers, each of which measured 10000µm 500µm 70µm (L W depth D).
To establish flow in these chambers, medium was loaded into 1-ml BRANDZIG syringe
with

25-gauge

needles.

These

syringes

were

joined

to

#30

Cole-Parmer

polytetrafluoroethylene (PTFE) tubing (inner diameter, 0.3 mm), which was connected to
pre-bored holes in the microfluidic device. Tubing was also placed on the opposite end of
the chamber to direct the effluent to a waste container. Syringes were mounted to syringe
pumps (Pico Plus Elite, Harvard Apparatus), and flow was maintained at 0.1 µl per min for
all experiments.

Biofilm growth
Overnight cultures of C. albicans were grown at 30°C with shaking in YPD prior to the
start of biofilm experiments. Cultures were normalized to an OD 600 of 0.5 in RPMI, ASMi
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or Urine medium. Cells were inoculated into a microfluidic chamber (completely filling its
inner volume), and then allowed to rest for 1h at 37°C to permit cells to attach to the glass
surface. The devices were then run at 0.1 µl per min at 37°C and imaged by confocal
microscopy (see below) at time intervals that varied per experiment as noted in each figure.

To measure strength of attachment of biofilms, biofilms were grown in three media for
24h. The flow rate was increased to 500 µl per min for three mins. Confocal images were
taken before and after the mechanical stress treatment.

For invasion experiments, we grew the resident biofilm for 24 h at a flow rate of 0.1 μl
per/min at 37°C, after which we introduced the invading strain (adjusted to an OD600 of
1.0) at the same flow rate for 2h by switching the chamber inlets to new tubing connected
to new syringes containing the invading strain. Confocal images were taken before
invasion, 2h and 24h after invasion protocol.

Microscopy and image analysis
Biofilms inside microfluidic chambers were imaged using a Zeiss LSM 880 confocal
microscope with a 40/1.2 numerical aperture (NA) or 10/0.4 NA water objective. A 488nm laser line was used to excite GFP, and a 594-nm laser line was used to excite mKate2.
All quantitative analysis of microscopy data was performed using BiofilmQ [23].

To calculate the volume of invader around the resident, a custom python script was built.
For each replicate image stack, the corresponding BiofilmQ generated data was loaded
into the python script. The BiofilmQ data is composed of cubes from each laser channelinvader or resident – and every cube contains volume and 3D location data. To find the
volume of invader around each resident, the script looped through the resident cubes and
found the invader cubes with centroids (center of mass of a cube) within a range of 15
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µm from the centroid of the focal resident. The volumes of these invader cubes were then
summed and stored in a .cvs file.

3.5 Conclusions

The incidence of C. albicans infections have been increasing in recent years and clearing
these infections have become a significant medical challenge [5]. Biofilms particularly are
very robust and resistant to a variety of treatment methods. Here, we sought to study C.
albicans biofilms grown in different nutrient environments and characterize their biofilm
properties. Given C. albicans’s metabolic flexibility we were curious to see to what extant
their biofilm characteristics would differ in variable nutrient niches. We demonstrated that
the biofilm architecture and biovolume accumulation under flow were distinct across three
nutritional environments. Finally, we show that new C. albicans cells can invade an
existing biofilm in a density packing dependent manner. The identification of this novel
characteristic could shed light into C. albicans biofilm dynamics especially in filamentous
biofilms.

Few studies have looked at metabolic flexibility of C. albicans, especially its effect on
biofilm characteristics. We show that growth and morphology but not attachment in a flow
system is dependent on the available nutrients. We speculate that the metabolic pathway
C. albicans chooses as result of available nutrients ultimately effects its growth dynamics.
In a nutrient rich environment like RPMI, it can quickly accumulate biomass and form a
robust biofilm. These biofilms are also very strongly attached to their surface in
comparison to biofilms grown in ASMi or urine. The precise pathway that is chosen by C.
albicans and the extent of its effect on biofilm dynamics is an important area for future
work.
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Our final series of experiments showed that C. albicans can colonize a previously
established C. albicans biofilm, in a combination of local biovolume density and total
biovolume dependent manner, over a relatively short colonization time of 2h. We also saw
that in urine media the new C. albicans is able to completely integrate into the existing C.
albicans biofilm. This suggests that C. albicans is suited to exploiting previously colonized
regions. We know that medical devices like catheters are colonized by C. albicans and
clearing these infections can be demanding [24]. On this basis we speculate that in less
densely packed biofilms, like those found in urine environments, C. albicans has evolved
surface occupation strategy best suited to taking advantage of previously colonized
surfaces.

Flow has shown to have effects on biofilm formation. In bacterial biofilms, surface
residence time [25], upstream surface motility in addition to the formation of biofilm
aggregates [26] have been shown to be affected by flow. There has been less investigation
of the effects of flow dynamics and shear on C. albicans biofilms. Some existing work
showed that biofilms formed under shear are more highly compacted and physically robust
relative to those grown in static conditions [27]. However, the combined effect of flow and
available nutrients have not been explored. We infer from our results that nutrient
availability plays a critical role in addition to shear stress. Understanding the precise
molecular mechanisms responsible for shear stress regulation and metabolic flexibility and
the interconnectedness between the two is an important for future study.
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3.6 Supplemental figures

FIG. S1a: C. albicans biofilms in RPMI media. Confocal 3D renderings of entire microfluidic
chambers with C. albicans biofilms grown under flow for 24h at 37oC

90

FIG. S1b: C. albicans biofilms in ASMi media. Confocal 3D renderings of entire microfluidic
chambers with C. albicans biofilms grown under flow for 24h at 37oC
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FIG. S1c: C. albicans biofilms in urine media. Confocal 3D renderings of entire microfluidic
chambers with C. albicans biofilms grown under flow for 24h at 37oC
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FIG. S2: C. albicans biofilms and mechanical stress. Representative confocal 3D renderings of
entire microfluidic chambers with 24h C. albicans biofilms in three different nutritional media before
and after simulation of mechanical stress – 5000 times flow rate increase for 3mins
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FIG. S3: Invasion dynamics. Representative 3D Confocal images of C. albicans invasion dynamics
at different time points in (A)RPMI (B) ASMi (C) Urine media.
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FIG. S4: Invasion experimental control. The total biovolume of resident strain in invasion and tubing
control experiments normalized to initial biovolume at 24h biofilm growth (n=3)
.

3.7 Appendix 1

Filamentation affects spatial distribution of genotypes in C. albicans biofilms

It has been well established biofilm function, characteristics and evolution are strongly
influenced by spatial arrangement of members with them [22]. Spatially constrained
interactions are well known to be important in ecology, for example, the occurrence of
diffusible goods is more common in spatially constrained populations. Additionally, many
phenotypes associated with biofilm formation and the pathogenesis of bacterial infections
like secreted factors such as digestive enzymes and nutrient chelating molecules occur in
higher frequency when certain genotypes are spatially close to one another [16], [23].
Recently, the spatiotemporal distributions of different genotypes and how they originate
have been explored in bacterial biofilms [24], however, such studies and characterization
in their fungal counterparts are still lacking.
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We characterized the patterns of spatial arrangement of two isogenic C. albicans strains in
a biofilm. The two strains are genetically identical but for the florescent protein they
express. We calculated autocorrelation length for biofilms grown in different media;
Autocorrelation length is a good measurement of lineage segregation because smaller
lengths indicate a more mixed population. Autocorrelation length of biofilms grown in
YPD where the C. albicans cells are majority in yeast morphology was used for comparison
Autocorrelation length of C. albicans grown in YPD was about double that of biofilms
with isogenic strains grown in RPMI, ASMi and Urine (Fig. 2A). This indicates that there
is more intermixing of isogenic strains when in filamentous morphology in comparison to
yeast morphology (Fig. 2B Sup. 3).

The C. albicans matrix – an integral component of C. albicans biofilms – assembly occurs
extracellularly making matrix assembly a cooperative community mechanism [25]. This
matrix sharing could potentially be responsible for intermixing of genotypes in filamentous
C. albicans biofilms. The secreted matrix components of yeast cells are not well recorded
and is likely they are different from its filamentous counterpart. Further investigation and
comparison of extracellular matrix and adhesion components produced by yeast and
filamenting C. albicans cells may help decipher the causes for their respective genetic
biofilm structures.
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FIG. A1: Spatial genetic structure within C. albicans biofilms. (A) Autocorrelation length – proxy
for degree of intermixing - for C. albicans biofilms with two isogenic strains grown in four different
nutritional media (n=3) (B) Representative 3D confocal renderings of isogenic C. albicans strain
biofilms grown in (i) RPMI media (ii) ASMi media (iii) urine media (iv) YPD media
.
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4.1 Abstract
Microbe-microbe interactions can strongly influence growth and biofilm formation
kinetics. For Pseudomonas aeruginosa and Candida albicans, which are found together in
diverse clinical sites, including urinary and intravenous catheters and the lungs of
individuals with cystic fibrosis (CF), we compared the kinetics of biofilm formation by
each species in dual-species and single-species biofilms. We engineered fluorescent protein
constructs for P. aeruginosa (producing mKO-κ) and C. albicans (producing mKate2) that
did not alter growth and enabled single-cell resolution imaging by live sample microscopy.
Using these strains in an optically clear derivative of synthetic CF sputum medium, we
found that both P. aeruginosa and C. albicans displayed increased biovolume
accumulation—by three- and sixfold, respectively—in dual-species biofilms relative to
single-species biofilms. This result was specific to the biofilm environment, as enhanced
growth was not observed in planktonic cocultures. Stimulation of C. albicans biofilm
formation occurred regardless of whether P. aeruginosa was added at the time of fungal
inoculation or 24 h after the initiation of biofilm development. P. aeruginosa biofilm
increases in cocultures did not require the Pel extracellular polysaccharide, phenazines, and
siderophores known to influence C. albicans. P. aeruginosa mutants lacking Anr, LasR,
and BapA were not significantly stimulated by C. albicans, but they still promoted a
significant enhancement of biofilm development of the fungus, suggesting a fungal
response to the presence of bacteria. Last, we showed that a set of P. aeruginosa clinical
isolates also prompted an increase of biovolume by C. albicans in coculture.
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4.2 Introduction
Microbial biofilm growth, even in monospecies contexts, involves the interplay of many
biological and physical factors that are dynamic in space and time (1–3). In many natural
environments, including numerous chronic infections, biofilms are multispecies mixtures
whose collective properties and dynamics may be difficult to predict from those of each
constituent’s monospecies biofilm growth. In the context of infection, the extent and kind
of interactions among different biofilm-dwelling microbes also govern clinically relevant
factors, such as drug resistance and virulence (4). For example, multispecies biofilm
growth has been implicated in conjunctivitis (5), tooth decay (6), prosthesis and wound
infections (7, 8), and respiratory diseases (9, 10). Clinical microbiologists are just starting
to

consider

the

multispecies

nature

of

pathogenic

biofilms

and

its

implications for prevention and treatment (11).

Exemplars of chronic, multispecies biofilm infections are those that occur consistently in
the lungs of patients with cystic fibrosis (CF), a genetic disorder in humans as a result of
mutations in the cystic fibrosis transmembrane conductance regulator. Disruption of this
protein’s function results in pathologies throughout the body including the accumulation
of highly viscous mucus in the lungs, which hinders normal mucociliary clearance. As a
result, bacterial and fungal pathogens that would otherwise be easily removed from healthy
lungs instead accumulate and lead to chronic infections (12). Chronic CF lung infections
are

caused

by

diverse

and

metabolically

flexible

populations and consortia, and they are extremely recalcitrant to antibiotic and phagocytic
clearance (13). While the ecology of the infecting species shapes the community and
potentially has a profound influence on disease severity in the CF lung, it remains poorly
understood (9). Given that the spatial interactions of pathogens can strongly affect disease
outcome (14), we aimed to create an experimental model in vitro to investigate the biofilm
formation kinetics of one or more species in coculture. Studies of multispecies biofilm
formation and biofilm dynamics in general benefit tremendously from high-resolution
imaging, which allows for studying the cell-length-scale behaviors and higher-order
structures

that

contribute

to
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the

community’s

cumulative

growth, organization, and function. However, imaging live biofilms in situ is often
difficult, if not impossible, in many natural contexts. A helpful strategy to mitigate this
problem is to reconstitute key features of the in-situ environment using an in vitro system
that is more amenable to imaging.

Here, we chose to study Pseudomonas aeruginosa and Candida albicans as representatives
of potentially interacting species in a polymicrobial CF infection, as both these species are
commonly isolated from CF lung infections and believed to be important co-pathogens in
patients (15). They are also thought to cooccur in other infection environments, including
trauma wounds and surrounding urinary catheters (16). C. albicans is a polymorphic and
opportunistic pathogen with the ability to form invasive hyphal filaments and drug-resistant
biofilms (17). P. aeruginosa is another opportunistic pathogen with diverse virulence
mechanisms, to which biofilm formation contributes directly and indirectly (18). P.
aeruginosa-C. albicans interactions are well studied in liquid and agar colony models.
Among the primary findings from this literature, P. aeruginosa has been shown to
preferentially attach to and form biofilms on C. albicans hyphae in static culture, eventually
killing them (19), but P. aeruginosa also inhibits the yeast-to-hyphal switch of C. albicans
in liquid and agar colony cultures, enhancing C. albicans survival (20). Prior work has
intimated a feedback loop whereby C. albicans produces ethanol, which increases biofilm
formation, inhibits swarming motility, and enhances the production of antifungal
phenazines on the part of P. aeruginosa (21, 22). These phenotypes in turn cause
downregulation of the central pathway that induces hyphal growth and inhibit
mitochondrial activity, stimulating further ethanol production by C. albicans (23). On the
other

hand,

some

in

vivo

experiments

using

a

zebrafish

model have indicated mutually enhanced virulence of the two species, suggesting that
environmental shifts may have strong impacts on the properties of cocultures of these
microbes (24). As local concentrations of metabolic products involved in interspecies
interactions are determined by the relative and absolute abundances, it is critical to
understand the dynamics of biofilm formation for each species in mixed culture.
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Using engineered strains with novel fluorescent protein constructs and microfluidic culture
with a modified synthetic sputum medium allowing for high-resolution imaging of C.
albicans and P. aeruginosa, we show that their biofilm architecture, rates of biovolume
accumulation, and total biovolume is higher for each species in coculture versus
monococulture. Growth stimulation for either species was not observed in planktonic
coculture conditions. This result is robust to different clinical strains of P. aeruginosa and
a variety of deletion mutants lacking factors known to participate in P. aeruginosa-C.
albicans interactions.

4.3 Results

Biofilm profiles in mono- and dual-species culture

We aimed to characterize the architecture of monospecies and dual-species biofilms of P.
aeruginosa and C. albicans under flow in a medium that represents the chemical
composition of CF sputum. Synthetic cystic fibrosis medium (SCFM2), developed and
refined by the Whiteley group (25, 26), is a field standard for this purpose, but this medium
is not optically clear due to the presence of reconstituted mucins. To generate an optically
clear medium for imaging—and supported by data showing that P. aeruginosa does not
degrade mucins itself (27)—we made a modified version of SCFM in which the major
mucin glycans were substituted for mucin; we term this modified medium artificial sputum
medium for imaging, or ASMi (see Materials and Methods). Each species’ growth profile
was the same SCFM2 as it was in ASMi (see Fig. S1 in the supplemental material).

P. aeruginosa and C. albicans were modified by allelic exchange to contain a chromosomal
construct for constitutive expression of tandem, codon-optimized copies of mKO-κ (P.
aeruginosa) or a single copy of mKate2 (C. albicans) (see Materials and Methods). mKOκ or mKate2 was selected for these studies for their brightness and because they could be
easily distinguished by fluorescence microscopy. The fluorescent protein expression
constructs did not alter the growth rate of either species (Fig. S2).
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To investigate mono- and dual-culture biofilm growth under flow of ASMi, we inoculated
derivatives of P. aeruginosa strain PA14 and C. albicans strains CAI4 either alone or
together in microfluidic devices (see Materials and Methods). Monococulture P.
aeruginosa chambers contained small biofilms with compact microcolonies on the order
of 10 µm in height (Fig. 1A). Monococulture biofilms of C. albicans contained scattered
clusters of groups of elongated yeast, many pseudohyphae, and some true hyphae that
spanned the height of the chamber (Fig. 1B). By visual inspection of confocal images, it
was quickly clear that the architecture and total accumulation of both species were quite
different in dual-inoculated conditions compared to the monococulture biofilms. In
coculture,

C.

albicans

had

largely

formed

true

hyphae

(Fig.

1C).

Quantification of C. albicans biovolume found a higher biovolume density near the base
of the biofilm in coculture conditions (Fig. 1D). In coculture, P. aeruginosa biofilms
localized to the hyphae of the highly filamentous C. albicans biofilms (Fig. 1C). The
biovolume accumulation of P. aeruginosa in coculture appeared greater, particularly in the
regions also colonized by C. albicans (0 to 12µm from the glass substratum) (Fig. 1D).
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FIG 1. Representative images of mono- and dual-species biofilms of P. aeruginosa and C. albicans.
Three-dimensional (3-D) renderings of 24-h-old monospecies biofilms of P. aeruginosa (A) and C.
albicans (B). Bottom panels show side views of the same images as those above them. (C) P.
aeruginosa-C. albicans dual-species biofilm at 24 h. Split channel of C. albicans biofilm (i) and P.
aeruginosa biofilm (ii) from the P. aeruginosa-C. albicans dual-species biofilm. (D) Heat maps of C.
albicans and P. aeruginosa biovolume as a function of height from the base substratum in mono- and
dual-species biofilms from panels A to C.

Quantitative analysis of image stacks from replicate biofilms collected from independent
experiments found that the total biovolume of both species increased substantially in
coculture relative to monococulture (Fig. 2A and B). The increase in biofilm biovolume in
coculture was significant by 24 h for C. albicans (Fig. 2A) and for P. aeruginosa (Fig. 2B).
In order to determine whether the increase in biovolume required the presence of P.
aeruginosa at the time of initial colonization, we added P. aeruginosa or a medium-only
control to C. albicans 24-h-old biofilms. In these experiments, the P. aeruginosa cells
were spiked into the chambers for 1 h, followed by a return to sterile ASMi medium. In
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control experiments, the same spiking procedure was performed but with sterile ASMi
medium.

While

C.

albicans

biofilm

accumulation

followed

its

normal

monococulture profile in the control condition, C. albicans biofilm development
significantly increased over the subsequent 12 h after the introduction of P. aeruginosa
(Fig. 2C). To determine whether any mechanical disturbance was sufficient to induce the
increase in C. albicans biomass accumulation, we introduced 1-µm-diameter inert
fluorescent beads to the chambers containing C. albica , but we saw no change in biofilm
architecture or biomass (Fig. S3).

The enhancement of C. albicans biofilm volume by the presence of P. aeruginosa was
not likely due to an overall improvement in growth when both species are present. In comparison experiments in which both organisms were cultivated planktonically in shaking
liquid ASMi medium, the reverse pattern was seen for C. albicans: its population density
was substantially lower in the presence of P. aeruginosa than in its absence (Fig. 2D),
recapitulating previously established antagonistic C. albicans -P. aeruginosa interaction in
liquid growth conditions (19, 28, 29). The population density of P. aeruginosa did not
change in the presence of C. albicans in liquid culture (Fig. 2E). We infer from this
outcome that the increase in accumulation of both species in microfluidic coculture is
specific to the biofilm environment. Because increased rate of biovolume increase can
result from higher retention of cells in the chambers due to decreases in active dispersal or
disruption by fluid flow, we quantified the cells in the effluent collected from the outlet of
the microfluidic chambers (see Materials and Methods). Significantly fewer C. albicans
cells were found in the effluent from dual-species biofilms (Fig. 2F). P. aeruginosa cell
concentration in effluent stayed the same in absolute terms (Fig. 2F) but was lower upon
normalization to the amount of biovolume in the biofilm chamber (Fig. S4).
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FIG 2. P. aeruginosa and C. albicans in mono- and dual-species culture. (A) Biovolume of C.
albicans in mono- and dual-species biofilms (n= 24). (B) Biovolume of P. aeruginosa in mono- and
dual-species biofilms (n= 24). (C) Biovolume of C. albicans biofilms initially grown in mono and
coculture, with the addition of P. aeruginosa at the time point indicated by the vertical arrow. For the
control, sterile medium was added in place of P. aeruginosa (n= 18). (D) Fluorescence counts of C.
albicans in mono-and dual-species shaking liquid cultures (n= 10). (E) Fluorescence counts of P.
aeruginosa (in arbitrary units [A.U.]) in mono- and dual-species shaking liquid cultures (n= 10). (F)
Dispersing cells of P. aeruginosa and C. albicans in mono- and dual-species biofilms (n= 11). Error
bars in panels A to E denote standard deviations; error bars in panel F denote standard errors. *, P,0.05
by Wilcoxon signed-rank test with Bonferroni correction, ns, not significant.
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Exploration of P. aeruginosa genes potentially involved in augmenting C. albicans
biofilms in coculture.

We repeated the mono- and coculture experiments above with mutants of P. aeruginosa
that have been implicated in altered biofilm morphology or interspecies interaction in prior
work. Analyses included mutants defective in the Pel exopolysaccharide production
(∆pelA [30, 31] and ∆wspR[32]), metabolic regulators and products important for biofilm
formation (∆anr[33] and ∆phz[34]),extracellular adhesins (∆bapA[35], ∆pilY1[36]),
quorum sensing (∆lasR[37]), and siderophore production (∆pvdApchE[38]). C. albicans
increased its accumulation by an order of magnitude or higher in biofilms with any of these
mutants, maintaining the trend seen with wild-type P. aeruginosa PA14 (Fig. 3A and Fig.
S5). In contrast, not all P. aeruginosa mutants were equal in their capacity for biofilm
formation or for stimulation of biofilm biovolume in the presence of C. albicans (Fig. 3B).
The ∆pelA and ∆wspR mutants were not defective in biofilm biovolume compared to the
wild type, which is consistent with the low detection of Pel extracellular matrix
carbohydrate (Fig. S6). Thus, the increased biovolume of P. aeruginosa was not due to
increased P. aeruginosa matrix production. Previously characterized mutants defective in
secreted phenazine toxins and pyochelin and pyoverdine siderophores also caused the
stimulation of C. albicans biofilm accumulation. P. aeruginosa mutants with lower levels
of monospecies biofilm (∆anr, ∆lasR, ∆bapA, and ∆pilY1) were less stimulated by C.
albicans at the 24-htime point. It is interesting to note that the amount of P. aeruginosa
biofilm biomass present did not correlate with the degree of biomass increase in C. albicans
(Fig. 3C); that is, any addition of P. aeruginosa, regardless of its native biofilm-producing
capacity, was sufficient to produce a similar increase in accumulation of C. albicans.
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FIG. 3 Deletion mutant assays and medium influent assays to explore the causes of mutual
enhancement between P. aeruginosa and C. albicans in biofilms. (A) Biovolume of C. albicans
grown in dual-species biofilms with P. aeruginosa deletion mutants at 24 h (see main text for mutant
descriptions, n= 9 to 24). (B) Biovolumes of mono- and dual-species P. aeruginosa biofilms at 24 h (n=
9 to 24). All error bars indicated are standard errors. (C) The mean values of C. albicans biovolume are
plotted against the corresponding mean value of wild-type (WT) P. aeruginosa PA14 and mutant
biovolume from their respective dual-species biofilms. There is no significant correlation between the
two (linear correlation analysis; P= 0.391; r2= 0.107). *, P,0.05 by Wilcoxon signed-rank test with
Bonferroni correction.

P. aeruginosa-C. albicans interaction is robust to CF isolate variation.
After documenting that wild-type PA14 could induce an increase in biofilm biomass
accumulation of C. albicans, we were curious to see whether this effect was consistent
across recent CF clinical isolates of P. aeruginosa as well. To explore this question, we
obtained P. aeruginosa clinical isolates from a patient who was infected with both P.
aeruginosa and C. albicans, and we grew them in mono- or coculture with C. albicans in
our microfluidic model underflow of ASMi. We found that C. albicans biofilm increased
significantly in coculture with all clinical isolates, consistent with the results reported
above for wild-type PA14 (Fig. 4A). Likewise, for all but one isolate, the biofilm growth
of P. aeruginosa was greater in coculture with C. albicans than it was in mono coculture
(Fig. 4B). Though all clinical P. aeruginosa isolates prompted an increase in C. albicans
biofilm accumulation, there was some variance in the degree to which this was the case
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(Fig. 4A). This variation made us wonder whether the spatial association between C.
albicans and different clinical isolates of P. aeruginosa might differ as well. To assess this
possibility, we grew the different clinical isolates together with C. albicans, acquired highresolution images of coculture biofilms, and quantified the spatial cooccurrence of the two
species via their density correlation (39). When averaged across all image replicates, the
spatial correlations between C. albicans and clinical isolates of P. aeruginosa generally
were not different from that between C. albicans and wild-typePA14 (Fig. 4C). After
visualizing the density correlation measurement at high spatial resolution, on the other hand
(Fig. 4D), it was clear that for some clinical P. aeruginosa isolates, the spatial association
with C. albicans was homogenous, while for others it was patchy. Previous work has
suggested that heterogeneity within a strain population—here, with respect to spatial
cooccurrence with P. aeruginosa and C. albicans —can impact survival in variable
environmental conditions (40–42). The significance of this result for the infection ecology
of these two species is not yet clear, but it is notable that among isolates of P. aeruginosa
from the same patient, the architecture of joint biofilms with C. albicans can differ
substantially at the micrometer scale (Fig. 4D) even when they appear to be the same or
similar when averaged on a larger spatial scale (Fig. 4C).
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FIG. 4 Biomass accumulation, density correlation analysis, and visualization of C. albicans in
coculture with different CF clinical isolates of P. aeruginosa. (A) Biovolume of C. albicans grown
as dual-species biofilms with P. aeruginosa clinical isolates along with wild-type (WT) PA14 for
comparison at 24 h (n = 18). (Biovolumes of P. aeruginosa clinical isolates in mono and coculture and
dual culture with C. albicans at 24 h (n = 18). (C) Global density correlation measurements of WT P.
aeruginosa and clinical isolates and C. albicans biofilms (n = 6). *, P, 0.05. (D) Visualization of dualspecies biofilms of P. aeruginosa and C. albicans. From top to bottom, spatially resolved density
correlation, 3-D renderings of dual-species biofilms, C. albicans channel split, and P. aeruginosa
channel split.

4.4 Discussion

Interest in multispecies biofilms including microbes from different domains of life has been
intensifying in recent years, as it is increasingly appreciated that many microbial
communities—both inside and outside host organisms—are polymicrobial (43). One of the
most highly referenced examples of polymicrobial infections are those within the lungs of
patients with CF, and two of the common members of these communities are the
opportunistic pathogens P. aeruginosa and C. albicans (12). Here, we sought to compare
the kinetics of biovolume accumulation in mono- and dual biofilms of these two organisms
using a new model of biofilm growth under flow of optically clear artificial sputum
medium. We demonstrated a marked increase of biofilm biomass accumulation as well as
a decrease in cells in biofilm effluent in dual-species culture relative to mono and coculture.
These results were robust to a variety of mutant and clinical strain backgrounds of P.
aeruginosa, and they contrast with the findings of some previous studies of these two
organisms in static liquid or agar colony culture (44, 45). We identify an important element
driving the increase in biomass accumulation as fluid flow in the dual species biofilm
milieu, which is a key novelty of this experimental approach for the study of P. aeruginosaC. albicans interactions.

Extensive prior work has shown that P. aeruginosa and C. albicans interact with each other
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through a complex web of secreted factors, including phenazines, siderophores, ethanol,
and quorum-sensing autoinducers, which altogether alter environmental iron availability,
pH, and oxygen tension. Under static culture conditions (i.e., liquid batch culture or agar
colonies), the net result of these interactions is usually antagonism of P. aeruginosa against
C. albicans. It is important to note as well that secreted factors from each species have
different and sometimes opposite effects on each other’s propensity to produce biofilms or
to remain in a dispersive, planktonic state (28, 46). As noted above, when flow - known to
impact microbial physiology and surface interaction - is introduced into the two-species
system, we see increased filamentation of C. albicans and increased biofilm biomass
accumulation by both species, accompanied by a decrease in cells exiting the chamber.

While at first glance this may give the impression of mutual benefit, it is also possible that
the two species are simply competing for access to space and resources by
upregulating adhesion factors (47–49). But why is P. aeruginosa no longer able to directly
antagonize and kill C. albicans, as has been shown previously in static culture? We
speculate that introduction of flow fundamentally changes the secreted solute environment
created by the two organisms, perhaps with some secreted factors more strongly retained
in the biofilm matrix than others, and that this change in solute environment relative to
static culture shifts the ecological pattern of biomass accumulation to one in which both
species are augmented. It is also possible that over time the dual-species biofilms become
densely packed enough to block flow within some regions, allowing secreted products and
variation in iron/oxygen availability to accumulate in a patchy manner that contributes to
induction

of

biofilm

production

by

both

species.

The precise spatial patterns of exoproduct accumulation in relation to cells and the highly
complex matrix that Candida secretes is an important area for future work (50–52).

Our deletion mutant analysis included all the major classes of behavior in P. aeruginosa
currently known to mediate solute-based interactions with C. albicans, but in all cases, the
presence of P. aeruginosa caused qualitatively the same increase in C. albicans biofilm.
This suggests that there may be other factors in addition to flow-mediated changes in solute
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environment contributing to our results. For example, the introduction of shear stress under
flow is an entirely new environmental stimulus relative to static culture, and one which is
known via extensive work to be crucial to microbial ecology and evolution (53–58). The
flow regime can dramatically alter the morphology and resilience of bacterial biofilms
down to their cellular resolution architecture (59, 60), with important implications for
pathogenesis in the case of infections (61). Adaptation to the challenges of flow at
submillimeter spatial scales has influenced the evolution of bacterial surface motility (2),
optimal growth rate in porous media (62), surface colonization mechanisms (63–65),
extracellular matrix secretion (66, 67), bacterial cell shape (64, 68–70), planktonic
aggregate formation (71), and biofilm community assembly and function (62, 72–75),
among many other examples.

The range of spatial structures of P. aeruginosa clinical isolates that we observed in dualspecies biofilms with C. albicans suggests the possibility of between-strain variance in
spatial occupation strategy within the CF lung. Since the clinical isolates come from a
single CF patient, this variation in biofilm morphology could be the outcome of selection
in different spatial locations in the lung, which may have variable C. albicans abundance
or exposure to antibiotics, toxins, mutagens, nutrient availability, or host immune attack
(40, 41). Although the increase in biovolume of both species in dual P. aeruginosa-C.
albicans biofilms varied to an extent, increase of C. albicans accumulation was consistent
across P. aeruginosa isolates. This result prompts us to speculate that the chance encounter
of C. albicans with P. aeruginosa in the CF environment could ultimately lead to changes
in disease progression by altering the tendency of the fungus to locally accumulate.

In light of our results, it is important to note that the flow regime has documented effects
on biofilm formation for both P. aeruginosa and C. albicans. The surface residence time
of P. aeruginosa, for example, increases linearly as shear stress increases (76), and flow
promotes upstream surface motility in addition to the formation of bio- film aggregates
(77). P. aeruginosa has also recently been shown to be highly responsive to mechanical
stress induced by flow, with downstream effects on biofilm formation that have yet to be
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fully clarified (36, 78). There has been less investigation of the effects of shear flow on C.
albicans biofilms: existing work does not agree completely on whether shear stress
increases total biomass of C. albicans biofilms but does agree that biofilms formed under
shear are more highly compacted and physically robust relative to those grown in static
conditions (79). Importantly, given that dual-species culture produced substantial biomass
accumulation for both species relative to mono- coculture under the same flow conditions,
flow-induced shear cannot on its own explain our results. Rather we infer that a
combination of physical forces resulting from flow in addition to biological interaction
between the two species must be responsible for the results obtained here. Dissecting the
precise molecular mechanisms of these interspecies interactions is an important area for
future study that may bear directly on the outcome of multispecies biofilm growth in the
context of infection.

Beyond their prevalence in lung infections among patients with CF, P. aeruginosa and C.
albicans individually are among the most common agents of nosocomial infection
currently known (16). They are both frequently isolated from device-related infections,
including implanted medical devices, prosthetic implants in wounds and joint
replacements, and urinary catheters (16). Both species participate in multispecies
infections, for example, with Staphylococcus spp. (80–82), with Streptococcus spp. (83,
84), and with each other (85). Reports of dual isolation of P. aeruginosa and C. albicans
are increasingly reported in the clinical literature in sites such as ventilator tubing (86), and
our results of biofilm dual-species culture in microfluidic devices suggest that dual
Pseudomonas-Candida biofilms may be especially problematic in this setting because they
tend to accumulate more biofilm biomass together than alone. Such rapidly accumulating
biofilms can potentially clog catheter flow environments and seed systemic infections as
cells disperse from the device-attached biofilm into the bloodstream.

Though recent studies have made tremendous strides in imaging microbiomes within in
situ samples that have been fixed (87–90), dissecting live microbial community structure
in space and time within native environments remains a challenging task and one of the
important frontiers of modern microbiology. Here, we use an in vitro model with medium
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tuned to the CF sputum environment to assess live biofilm population dynamics for both
members and find that this step toward environmental realism has a strong impact on the
ecology of dual-species biofilms of P. aeruginosa and C. albicans. Many native factors are
still missing, however: the mucosal environment is quite different in the native lung, for
example, and recent work has suggested that mucus has a strong impact on P. aeruginosa
physiology, including reducing its propensity toward virulence and biofilm formation (91,
92). Though not an exact match to the in-situ infection environment, our system
nevertheless suggests that modest changes to the environmental context in which
multispecies interactions are studied can have a large impact on the observed outcome,
namely, in this case, a shift toward far higher accumulation of biofilm on the part of P.
aeruginosa and C. albicans when they are together versus when they are alone. On the
basis of this observation, we specula pushing toward realism and high-resolution image
analysis of biofilm communities will yield important and unexpected insights for many
other microbial systems.

4.5 Materials and Methods
Strains and media.
Table 1 includes a full list of strains and plasmids used in this study. Strains of P.
aeruginosa are either derivatives of strain PA14 or clinical isolates. C. albicans strains are
derivatives of strain CAI4. All strains were grown on LB (10 g tryptone, 5 g NaCl, 5 g
yeast extract [all amounts per liter]) and artificial sputum medium for imaging (ASMi) (P.
aeruginosa) or YPD (10 g yeast extract, 20 g peptone, and 20 g dextrose [all amounts per
liter]) and ASMi (C. albicans). The medium recipes and concentrations of reagents used
for ASMi are listed below at the end of Materials and Methods. All chemicals and reagents
were purchased from Millipore Sigma unless otherwise stated.
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Table 1: Strains and plasmids used in this study

Plasmid and strain construction.
All restriction enzymes and ligase were purchased from New England Biolabs, and PCR
reagents were purchased from Bio-Rad. The P. aeruginosa tandem codon-optimized
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version of mKO-κ was custom synthesized by Invitrogen. The construct contains two
copies of mKO-κ in tandem, each with its own ribosome binding site, and with different
codon composition to prevent excision by recombination. Fluorescent P. aeruginosa
derivatives were constructed by amplification of the flanking regions upstream and
downstream of the Tn7 att site and fusion of the custom fluorescent protein construct to a
synthetic tac promoter for high expression from a single chromosomal locus. This fused
construct was cloned into the pMQ30 plasmid used for allelic exchange in P. aeruginosa
(93). This plasmid was then introduced into Escherichia coli S17-lpir by electroporation
and conjugated into P. aeruginosa, and recombinants were obtained using selection on
gentamicin and sucrose counter-selection for loss of the integrated plasmid backbone. For
C. albicans, a single codon-optimized version of mKate2 was custom synthesized by
Invitrogen. The RP10 integrative plasmid, pACT-GFP (94), has been shown to have
constant expression levels through C. albicans growth cycle. We replaced the green
fluorescent protein (GFP) in pACT-GFP (94) with mKate2. For transformation into C.
albican, the mKate2- containing plasmid was linearized by BglII restriction digestion and
concentrated using the Zymo Research DNA Clean & Concentrator-5 kit (catalog no. 11303), and 1mg was electroporated into electrocompetent C. albicans CAI4 prepared as
previously described (95). Prototrophic recombinants were selected for on uracil drop-out
medium.

Liquid growth curve and fluorescence measurements.
P. aeruginosa strains were grown at 37°C shaking in LB overnight prior to growth curve
experiments. The following morning, cultures were back- diluted to an optical density at
600 nm (OD600) of 0.01 in ASMi in 10-ml glass tubes with 2 ml medium (for fluorescence
growth curves) or 50-ml Falcon tubes with 30 ml of medium (optical density growth
curves), rotating at 250 rpm on an incubated orbital shaker at 37°C. C. albicans strains
were grown at 30°C shaking in YPD overnight prior to growth curve experiments. They
were cultivated overnight at 30°C to maintain cells in yeast form prior to the start of growth
curve

or

biofilm

experiments

(see

below).

The following morning, cultures were back-diluted to an OD 600 of 0.01 in ASMi in 10121

ml glass tubes with 2 ml medium (for fluorescence growth curves) or 50-ml Falcon tubes
with 30 ml of medium (optical density growth curves), rotating at 250 rpm on an incubated
orbital shaker at 37°C. Fluorescence measurements were made using a Synergy Neo2 every
6 h. A 543-nm excitation source was used to excite mKO-κ, and a 594-nm excitation source
was used to excite mKate2. Optical density measurements were made every hour using a
benchtop spectrophotometer (CWA Biowave CO8000 cell density meter).

Microfluidic device assembly.
The microfluidic devices were made by bonding polydimethylsiloxane (PDMS) chamber
molds to size #1.5 cover glass slips (60 mm X 36 mm [length L X width W], ThermoFisher, Waltham, MA) using standard soft lithography techniques (96). Each PDMS mold
contained four chambers, each of which measured 3,000µm X 500 µm X 75 µm (L X W
X Depth D). To establish flow in these chambers, medium was loaded into 1-ml BD plastic
syringes with 25-gauge needles. These syringes were joined to #30 Cole-Parmer
polytetrafluoroethylene (PTFE) tubing (inner diameter,0.3 mm), which was connected to
prebored holes in the microfluidic device. Tubing was also placed on the opposite end of
the chamber to direct the effluent to a waste container. Syringes were mounted to syringe
pumps (Pico Plus Elite, Harvard Apparatus), and flow was maintained at 0.1 ml per min
for all experiments.

Biofilm growth, matrix staining, and CFU counts.
Overnight cultures of P. aeruginosa were grown at 37°C with shaking in LB, and overnight
cultures of C. albicans were grown at 30°C with shaking in YPD prior to the start of biofilm
experiments. Cultures of both strains were normalized to an OD 600 of 0.05 in ASMi
medium. If dual species biofilms were to be started, equal volumes of OD-equalized strains
were mixed, inoculated into a microfluidic chamber (completely filling its inner volume),
and then allowed to rest for 1 h at 37°C to permit cells to attach to the glass sur- face. The
devices were then run at 0.1 ml per min at 37°C and imaged by confocal microscopy (see
below) at time intervals that varied per experiment as noted in each figure. All experiments
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were repeated with at least five biological replicates with three or more technical replicates
on different days. Total replicates for each experiment are noted in the figure legends for
each data set in the text and supplemental material.
Wisteria floribunda lectin stain (Vector Labs) conjugated to fluorescein dye was used to
visualize Pel polysaccharide produced by P. aeruginosa (31). The lectin was added to the
medium in syringes for these experiments such that biofilms would be exposed to the
lectin-dye conjugate for the entire period of biofilm growth (20ml stock lectin solution per
ml of medium, per the manufacturer’s protocol recommendation from a stock solution of
2-mg/ml dye conjugate). Biofilms were inoculated as noted above for these experiments
and grown for 24 h prior to imaging.
To compare growth rates of P. aeruginosa and C. albicans in turbid synthetic cystic fibrosis
medium (SCFM) (25) and optically clear ASMi, both species were grown overnight, P.
aeruginosa in LB at 37°C and C. albicans in YPD at 30°C in 10-ml glass tubes with 2 ml
of medium. The following morning, the cultures were back-diluted to an OD600 of 0.01 in
either SCFM or ASMi in 50-ml Falcon tubes with 30 ml of medium, rotating at 250 rpm
in an orbital shaker at 37°C. One milliliter of culture was taken from the Falcon tube at
different time points, and serial dilution was performed and plated on LB agar for P.
aeruginosa and YPD agar for C. albicans. The number of CFU from each plate was
recorded and used to calculate growth rates measured by CFU per milliliter per time.
To measure passive dispersal from biofilms as a result of exposure to fluid shear, biofilms
of both species were grown as noted above in ASMi medium for 24 h, after which the
outlet tubing of the micro- fluidic device was changed to ensure we were measuring
dispersal only from the biofilms within the chambers themselves. The flow rate was
increased to 500ml per min, and outflow was collected. Serial dilutions were performed
and plated on LB agar for P. aeruginosa and YPD containing 50 mg/ml chloramphenicol
for C. albicans. The number of CFU from each plate was recorded and used to calculate
the CFU/milliliter culture density emerging from the chambers. This experiment was
repeated for 11 biological replicates with independent overnight cultures.
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Microscopy and image analysis.
Biofilms inside microfluidic chambers were imaged using a Zeiss LSM 880 confocal
microscope with a 40 X /1.2 numerical aperture (NA) or 10 X /0.4 NA water objective. A
543-nm laser line was used to excite mKO-κ, and a 594-nm laser line was used to excite
mKate2. A 458-nm laser line was used to excite Wisteria floribunda lectin stain in the case
of Pel quantification experiments. All quantitative analysis of microscopy data was
performed using BiofilmQ (39). Three-dimensional (3-D) renderings of biofilms in Fig. 1
and 4 were made using Paraview.

Statistics.
All statistical analyses were performed in GraphPad Prism. All reported pairwise
comparisons were performed using Wilcoxon signed-rank tests, and multiple comparisons
were performed by Wilcoxon signed-rank tests with Bonferroni correction. All error bars
indicated standard errors unless otherwise noted.

Artificial sputum media for imaging (ASMi).
The stocks for the base were Na2 HPO4 (0.2 M, 0.69 g/ 25 ml), NaH2PO 4 (0.2 M, 0.71
g/25 ml), KNO 3 (1 M, 2.53 g/25 ml), K2 SO4 (0.25 M, 1.09 g/25 ml). Additional stocks
were glucose (20% [wt/vol]) autoclave, L -lactic acid (1 M) (adjust pH to 7 with NaOH),
CaCl2·2H2O (1 M, 3.68 g/25 ml), MgCl2·6H2O (1 M, 5.08 g/25 ml), FeSO4·7H2O (1
mg/1 ml) syringe, N-acetylglucosamine (0.25 M, 1.383 g/25 ml), tryptophan (0.1 M, 1.021
g/50 ml). Reagents were DNA (herring sperm DNA), fucose, GalNAc, galactose, choline
chloride,

sodium

octanoate,

yeast

synthetic

dropout

excluding

Trp,

NaCl,

morpholinepropanesulfonic acid (MOPS), KCl, NH4Cl, and NaOH. Preparation of ASMi
(500 ml) (2 in 250 ml) was as follows: 1) add 400 ml distilled H 2O (diH2 O) and stir bar
to a clean beaker; 2) while stirring add 3.250 ml Na 2HPO 4 stock, 3.126 ml NaH2PO4
stock, 174 ml KNO 3 stock, 542 ml K 2SO4 stock, 2 g yeast synthetic dropout – Trp, 1.516
g NaCl, 1.046 g morpholinepropanesulfonic acid (MOPS), 558 mg KCl, 62 mg NH4Cl,
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4.65 ml L-lactic acid stock, 1.365 ml glucose stock, 875 ml CaCl2·2H2O stock, 600 ml N
acetylglucosamine, 500 ml FeSO4·7H2O, 330 ml tryptophan stock, 303 ml MgCl2·6H2
O, 300 mg DNA, 0.007 g choline chloride, 0.022 g sodium octanoate (replacement 1,2dipalmitoyl-sn-glycero-3-phosphocholine [DPPC]), 400 mg fucose, 125 mg GalNAc, 90
mg galactose, (replacement for mucin; these are mucin sugars); 3) adjust pH to 6.8 with
HCl or NaOH and add distilled H2O to 500 ml; 4) filter sterilize.
Considerations and references.
Considerations follow. (i) It lacks sphingolipids and surfactant proteins, which are
moderately abundant. (ii) Mucin sugars are used instead of mucin (97). (iii) Reports of
some concentrations vary from source to source. References follow: DPPC (98) (octanoate
and choline are used instead at the same concentrations; 2:1 octanoate-choline, since DPPC
has two lipid chains per choline. DPPC molarity for choline and 2 that for octanoate), DNA
(98), and mucin (98).

4.6 Supplemental figures

FIG. S1 Growth curves of (A) C. albicans and (B) P. aeruginosa in standard SCFM2 medium with
reconstituted mucin and in ASMi medium containing only mucin sugars without full length mucin
polymers (n = 6). All error bars indicated are standard errors.
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FIG. S2 Growth curves in ASMi medium of (A) wild-type C. albicans CAI4 or C. albicans_ mKate2
and (B) wild type P. aeruginosa PA14 or P. aeruginosa_ mKO-κ (n = 6). All error bars indicated are
standard errors.
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FIG. S3 Inert fluorescent beads were introduced to C. albicans expressing mKate2 biofilms to test
for the effect of mechanical disturbance on C. albicans biofilm growth. (A) Biovolume of C.
albicans with and without fluorescently labeled beads added to the influent medium (n = 6). (B)
Representative image of C. albicans biofilms grown with fluorescently labeled beads shown in red at
the 24-h time point (C) Representative image of C. albicans biofilm in the absence of fluorescent beads
in influent medium at 24-h time point. All error bars indicated are standard error.

FIG. S4 Passive dispersing P. aeruginosa CFU per unit biovolume. Dispersing P. aeruginosa
obtained from plating cells from the outflow of the microfluidic chamber normalized to biovolume of
cells present in the microfluidic chamber (P < 0.001; n = 6). Reported pairwise comparisons are the
result of Wilcoxon signed-rank test. All error bars indicated are standard errors.
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FIG. S5 Slopes of C. albicans growth yields. Best fit lines were generated by fitting kinetic biofilm
biovolume data by least square regression. The slopes of the best fit lines for growth yields of C.
albicans grown in the presence of the P. aeruginosa mutants were statistically different from the slope
determined for C. albicans grown alone. (P < 0.001 for slope of C. albicans with P. aeruginosa mutants
compared to slope of 0 for C. albicans alone as determined by extra sum-of-squares F test.)
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FIG. S6 The matrix polysaccharide Pel was stained and quantified in P. aeruginosa strain PA14
biofilms using a fluorescent dye bound to Pel-specific lectin in M63* medium plus arginine, a biofilm
assay medium [99]), and ASMi medium (P < 0.001; n = 6). Reported pairwise comparisons determined
by Wilcoxon signed-rank test. All error bars indicated are standard errors. *5X M63 is as follows: 17.5
g dibasic potassium phosphate, 7.5 g monobasic potassium phosphate, 5.0 g ammonium sulfate into
sterile 500 ml H2O. M63 is supplemented to obtain working concentrations of 0.4% l-arginine-

monochloride and 1 mM MgSO4.

4.7 Appendix 2
Effect of P. aeruginosa supernatant on C. albicans biofilms
We found that the addition of P. aeruginosa supernatant caused a dramatic decrease in C.
albicans biofilm accumulation, most pronouncedly when C. albicans was inoculated in
coculture with P. aeruginosa (Figure 1A A and B). Importantly, the PBS control treatment,
in which C. albicans biomass was unaffected, demonstrates that addition of P. aeruginosa
supernatants to the biofilm chamber influent does not reduce C. albicans accumulation due
to a reduction of nutrient availability. Our first thought was that re-introduction of
phenazines (46) or rhamnolipid surfactants (101) to the influent media might be primarily
responsible for C. albicans biofilm biomass. However, supernatants from a P. aeruginosa
Δphz mutant, which produces no phenazines, resulted in the same outcome as introduction
of WT supernatants. Supernatants from ∆lasR mutant cultures, which lacks many quorum
sensing regulated secreted products including phenazines and rhamnolipids, were partially
effective compared to the effects of WT supernatants, suggesting that the effects were
likely multifactorial (Figure 2A). The observation that P. aeruginosa supernatant remained
partially effective after protease treatment supports the model that multiple factors
contributed to the effects on biovolume accumulation. Interestingly, it is worth noting that
all supernatant activity was lost after boiling.
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FIG. 1A Effect of P. aeruginosa supernatant on C. albicans biofilms (A) Biovolume of C. albicans
biofilm initially grown in monoculture, followed by addition of P. aeruginosa supernatant at the time
point marked by the arrow. (B) Biovolume of C. albicans mono species and dual species biofilms in
the presence of different media influent. PBS is used as a control for addition of P. aeruginosa
supernatants and media dilution. (n=6) (E) CLSM representative images of C. albicans and C. albicans
+ P. aeruginosa biofilms for conditions in C. For the control, sterile media was added in place of P.
aeruginosa at the same time point (n=6). * denotes < 0.05. All error bars indicated are standard

error.
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FIG. A2 Supernatants from P. aeruginosa mutants and enzyme treated supernatants. Supernatants
either from P. aeruginosa mutants or supernatant from P. aeruginosa PA14 wildtype treated with
Proteinase K, Dnase1 or boiled and then used to grow C. albicans biofilms to identify the component
in the supernatant responsible for decreased C. albicans growth yield (* denotes p<0.05; n=6). Reported
pairwise comparisons are the result of Wilcoxon signed-rank test. All error bars indicated are standard
error.

Previous studies have suggested that P. aeruginosa supernatants alone are not sufficient to
inhibit C. albicans viability but did not specifically examine their effect on biomass
retention to surfaces for biofilm production (19, 29). To explore this possibility, we grew
biofilms of C. albicans in monoculture for 24 hs under regular ASMi flow, allowing them
to reach their typical biomass steady state in biofilm chambers; after this 24 h period the
medium influent was switched to a 2:1 mixture of ASMi and P. aeruginosa culture
supernatant. After introduction of the supernatant, the C. albicans biofilms decreased
linearly in total biomass nearly to zero in 24 h (Figure 1A). Altogether these results indicate
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that the increased biomass accumulation of C. albican in the presence of P. aeruginosa is
dependent on the mass transport of P. aeruginosa secreted products out of the system.
When these supernatants are reintroduced, of C. albicans accumulation in the chambers
ceased, and any pre-existing biomass was greatly reduced over time. This could be due to
inhibited growth of C. albicans, inhibited attachment of C. albicans to substrata, induced
dispersal, or a combination of these factors.
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Conclusions
Microbes predominantly live in spatially structured communities called biofilms. These
communities are very dynamic in nature and are shaped by interactions with their external
environment and internally with other cells within the biofilm. These interactions lead to
the emergence of properties and characteristics distinct to the biofilm community. Such
biofilm-intrinsic characteristics impact the phenotypes of the cells within the biofilm; more
importantly however they also impact the community composition and function. Studying
community-intrinsic properties is, therefore, important for furthering our understanding of
clinical, applied, and environmental microbiology.

The above studies exhibit scenarios where observed changes in phenotypes that occurred
as a result of (i) microbial interactions that were not predictable from analyzing individual
planktonic members and (ii) complex external environments; both in terms of mechanical
forces like shear and nutrient media used. Therefore, biofilm properties are highly
dependent on the system they occur in and as the realism of their natural niche increases,
it enhances the probability of encountering and untangling biofilm-intrinsic properties in
that environment. More of such studies of microbial interactions and ecology in complex
environments that mirror natural environments are required, they will facilitate the
discovery of biofilm properties and the factors that trigger them.

Once biofilm-specific properties are identified, the next goal would be to move towards a
mechanistic understanding of the community-intrinsic properties. Molecular mechanisms
involved community properties are still not well understood. Studies that use sequencing
technologies combined with spatial and single cell analysis while maintaining an adequate
level of biotic and abiotic complexity are very few and far apart. The transcriptional
signatures across the biofilm could provide spatial information on metabolism and help
with providing a holistic understanding of the biofilm system. Further, combining
molecular biology techniques and high-resolution microscopy will we be able provide a
fuller understanding of community-intrinsic properties.
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